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ABSTRACT OF DISSERTATION
ENTRY AND EARLY INFECTION OF NON-SEGMENTED NEGATIVE SENSE
RNA VIRUSES
Paramyxoviruses, pneumoviruses, and other non-segmented negative
sense (NNS) RNA viruses have historically been of public health concern.
Although their genomes are typically small (up to 19kbs) they are able to inflict
large-scale detrimental pathologies on host cells. Human metapneumovirus
(HMPV) is a widespread pathogen and is a NNS RNA virus. HMPV results
respiratory tract infections and is particularly dangerous for preterm infants, the
elderly, and immunocompromised individuals. Other viruses within the NNS
RNA virus order include the deadly Ebola, Hendra, and Nipah viruses (EBOV,
HeV, and NiV), as well as the re-emerging measles virus (MeV). Despite their
public impact, there are currently very limited available FDA-approved
therapeutics and antivirals against NNS RNA viruses.
During the infectious cycle, viral surface glycoproteins play critical roles
in establishing infection. For most NNS RNA viruses, the attachment protein is
important for the tethering of a viral membrane to host cells, while the fusion
protein is responsible for the membrane merger of the virus and host. The fusion
protein of paramyxo-and pneumovirus proteins are class I proteins that are
folded into trimers, must be proteolytically cleaved to be functional, and are held
in a metastable prefusion conformation until the signal for fusion occurs. Upon
being signaled, the fusion protein undergoes dramatic essentially irreversible
conformational changes for membrane mixing. Because of its important role in
starting infection, F has garnered interest as a potentially powerful target against
infection. For paramyxoviruses, the ectodomain regions of F have been wellstudied; however, the hydrophobic nature of the transmembrane domain (TMD)
of the protein has resulted in difficulties in crystallization. To address this,
several biochemical assays have been utilized to address the function of the
TMDs of paramyxo-and pneumovirus fusion proteins. Although initially thought
to be solely a membrane anchor, the transmembrane domains of several
viruses have been shown to be important for the functionality of fusion proteins.
For some paramyxoviruses, replacement of the proteinaceous TMD resulted in
the premature triggering. Further studies showed that the TMDs of
paramyxoviruses and several other viral F proteins exist in isolation as trimers,
and these trimeric associations in turn drive trimeric associations of the full
protein. Studies of the HeV F TMD in isolation identified a leucine/isoleucine
(L/I) zipper as an important motif for TMD-TMD trimerization. Mutations to this
L/I zipper motif in the context of the full protein resulted in reduced surface
expression, and a loss of functionality. The L/I zipper was found to be present
in 140 paramyxo- and pneumovirus fusion protein TMDs. This work examines
whether
wh iimporether
the importance
of the L/I zipper in the context of another paramyxvovirus. We

used the model system, PIV5 F to dissect the role of the TMD L/I zipper
in expression
and We found that the (L/I) zipper plays important roles in
fusogenic
activity.
functionality of the PIV5 F protein, but not surface expression of the protein.
Following membrane merging, a series of events occur that facilitate the
release of viral contents into the host cell. The NNS RNA carried by the virus
into the cell is used as a template for viral replication and transcription; two
important steps in generation of viral progeny. In the life cycle of NNS viruses,
viral proteins assume multi-functional roles to optimize their replication and
spread. One of the key players during the course of infection is the matrix
protein (M). The matrix protein has been identified as a master regulator of viral
infection with most studies focusing on its roles in late-stage infection, during
assembly and budding of viral progeny. The matrix proteins of many enveloped
viruses have been shown to associate in high order oligomers to form a gridlike array underneath the plasma membrane, where they can induce
membrane curvature to allow for the budding of viral particles. Not surprisingly,
the absence of M in some NNS RNA viruses results in a significant viral titer
decrease. Interestingly, some recent studies show that the matrix protein has
other critical roles in viral infection such as immune modulation and host cell
translation antagonism. One of these newly uncovered roles for viral matrix
proteins involves the regulation of viral RNA synthesis. Studies with EBOV and
MeV demonstrate that the matrix protein is involved in early infection events,
as inhibits viral replication. To study the roles of the HMPV M protein in early
infection, we performed a spatiotemporal analysis of M in HMPV-infected cells.
We noted the presence of HMPV M within the nucleus during early infection.
Our knockdown studies of HMPV M indicate that HMPV M is a positive
regulator of viral replication and transcription, as in its absence, the rates of
mRNA and viral genomic RNA synthesis are dramatically reduced. Additionally,
within the NNS RNA virus order, HMPV M is the only matrix protein found to
bind calcium. We created alanine mutants to the calcium coordinating residues
of HMPV M and found that these residues were important in properly folding
the protein. Together, these findings contribute to our understanding of the
mechanisms of NNS RNA viral infection.
KEYWORDS: Paramyxovirus; Pneumovirus; Matrix protein; Fusion
protein; Membrane fusion; Viral replication.
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Chapter 1: BACKGROUND AND INTRODUCTION
Pathophysiology of NNS RNA viruses
Non-segmented negative sense (NNS) RNA viruses display a wide range
of pathogenicity in their hosts. [1]. Hendra virus (HeV), Nipah virus (NiV), rabies
virus (RV), and Borna disease virus (BDV) can infiltrate the central nervous
system, resulting in encephalitis and other serious neurological symptoms [2-4].
Additionally, paramyxoviruses and pneumoviruses are some of the leading
causative viral agents of respiratory tract illness [5, 6]. For example, infection with
respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) typically
result in bronchiolitis but can also manifest as more severe symptoms that may
require mechanical ventilation and/or cardiovascular support [7]. RSV and HMPV
infections are common in pediatric populations, and studies show that most people
by the age of 5 have already been infected; however, re-infections occur
throughout life [8]. HMPV and RSV also result in significant morbidity and mortality
in the elderly and immunocompromised [9-11]. Additionally, human parainfluenza
virus (hPIV) 1 and 3 pose significant health risks in lung transplant patients [12],
while PIV5 is non-pathogenic in humans but serves as a potent viral model system
for paramyxo-and pneumovirus studies [13, 14]. Other NNS RNA viruses such as
EBOV, for instance, affect the vascular system of non-human primates and
humans, potentially leading to hypervolemic shock, and can result in multi-organ
failure and resulting in a 25-90% fatality rate. Although some NNS RNA viruses
such as RV and measles virus (MeV) have effective vaccines [6, 15-17], for many
NNS RNA viruses, despite multiple ongoing trials, there are currently no FDAapproved vaccines and therapeutics for humans, and much of their treatment
involves supportive therapy [6, 18-22]. However, in a positive turn of events, a
three-antibody cocktail treatment against EBOV, REGN-EB3, was approved in
October 2020 [23], highlighting important strides in NNS RNA viral research.
Together, the current literature points out a dire need for a more detailed
understanding of the molecular details of NNS RNA viral infection to elucidate
novel therapeutic targets.
1

Public health impacts of NNS RNA viruses
While the impacts of positive stranded RNA viruses such as the newly
emerged SARS CoV-2 are at the forefront currently, NNS RNA viruses have also
historically contributed to severe disease not only in humans, but also in livestock,
plants, and fungi [2, 3, 24, 25]. Ebola virus (EBOV), RSV, and the re-emerging
MeV are some high-profile examples of NNS RNA viruses that have caused global
public health concern [26-28]. Although some NNS RNA viruses such as RV have
been present for centuries [3], the vast majority of emerging viruses are RNA
viruses [29]. With a tendency to jump from other species to humans, NNS and
other RNA viruses exploit a naïve host cell population with limited cross-immunity
to inflict deleterious effects [4, 29, 30].
Classification and morphology of NNS RNA viruses
NNS RNA viruses belong to the order Mononegavirales which consists of
eight

families:

Bornaviridae,

Filoviridae,

Mymonaviridae,

Nyamiviridae,

Paramyxoviridae, Pneumoviridae, Rhabdoviridae, and Sunviridae [31]. These
viruses are enclosed in a host-derived viral membrane, with a spherical, rod-like,
filamentous, or pleomorphic morphology [1, 2, 24, 25]. Their continuous negative
stranded genomes are up to approximately 19kb in length and encode between 510 genes [32, 33]. Some genes encode proteins directly involved in the viral
structure while others have non-structural properties. In general, the RNA is
arranged from 3N-P-M-G-L5; however, some NNS RNA viruses contain other
proteins such as SH, M2, NS, and additional as-yet uncharacterized proteins [3133] (Figure 1.1).
The RNP complex of NNS RNA viruses
NNS RNA genomes are encapsidated in a long, flexible, helical
ribonucleoprotein (RNP) complex, composed mainly of the nucleoprotein (N, NP)
functioning in close association with the RNA dependent RNA polymerase (RdRp)
complex. The RdRp is made up of the large protein (L) and the polymerase
cofactor phosphoprotein (P) [32, 34]. N/NP functions primarily by enclosing the
viral RNA in a continuous protein chain, providing protection against nucleases
2

[35], and allowing for the encapsidated NNS RNA to be used as a template for
both transcription and replication [32, 35]. This N/NP protein coat also circumvents
innate immune recognition such as responses from Toll-like receptors, Rig-I, and
interferon mediated response that may otherwise identify and respond to degrade
foreign RNA species in the host cell [34-36]. P is a multifunctional protein, and one
of its roles is to serve as a cofactor the for the viral polymerase [37]. It is also
reported to interact with host cell factors [38, 39]. For P, phosphorylation states, as
well as the extent of phosphorylation, play significant roles in viral replication and
in its interactions with other viral proteins and/or host factors [39, 40]. L, the largest
viral protein has RNA dependent RNA polymerase activity, and in concert, N, P,
and L facilitate viral replication of the NNS RNA viruses. [31, 35].
Surface glycoproteins of Paramyxo-and Pneumoviruses
Since NNS RNA viruses are enveloped, infection requires the energetically
costly process of fusing the viral membranes with their host target cells [41-43].
While some NNS RNA viruses encode a single protein G/GP that facilitates both
attachment and fusion, most require two distinct proteins to engage the process.
In general, the fusion protein (F) and attachment protein (G, GP, HN, or H) are
critical for entry of viruses into host cells—the attachment protein interacts with
cell-surface receptors to enable a virion to tether to a host cell. Then, after a virion
is oriented closely with a host cell, the fusion protein undergoes essentially
irreversible conformational changes to merge viral membranes with host cell
membranes [44-47]. F and G/GP/HN/H are the two surface glycoproteins present
on most NNS RNA viruses, are recognized by the host cell as antigens and thus
often serve as attractive antiviral targets [33, 47-49]. In addition to the fusion and
attachment proteins, some viruses such as parainfluenza virus 5 (PIV5), HMPV
and RSV have the small hydrophobic (SH) protein, which is a proposed viroporin
for HMPV and RSV [50, 51].
The attachment protein
In addition to roles in antigenicity, viral attachment proteins are important
determinants of tropism and may also function in triggering the fusion of viral and
3

host cellular membranes [52]. Paramyxo- and pneumo-virus attachment proteins
are generally classified as type II membrane proteins with a globular head, a stalk,
a transmembrane domain and a cytoplasmic tail [53].
Although paramyxo- and pneumo-virus attachment proteins exist as
homotetramers (dimer-of-dimers), each monomeric unit can bind to its respective
receptor molecule. In addition, certain paramyxo- and pneumo-virus attachment
proteins can recognize and bind sialic acid on host cell receptors. Indeed, the
designated names, H, HN, or G are based on their binding and/or catalytic activity
with sialic acid on the cell surface. For instance, hemagglutinin (H) mediates
hemagglutinin activity by binding to sialic acid; hemagglutinin-neuraminidase (HN)
mediates both hemagglutinin and neuraminidase by binding and cleaving sialic
acid; and glycoprotein (G) neither binds nor cleaves sialic acid. Instead, for some
viruses, G can bind ICAM, heparan sulfate, or other glycosaminoglycans. NiV and
HeV G proteins bind to ephrinB2 or ephrinB3 [53]. Interestingly, MeV H also
recognizes and binds to CD46, SLAM (CDw150), and nectin-4 on host cell
surfaces [46, 54, 55].
For paramyxoviruses, the viral attachment protein function not only
precedes fusion protein conformational changes, but also in essence triggers the
beginning of the fusion process mediated by the fusion protein. Aguilar et al. review
five mechanisms through which the attachment protein directly interacts with F,
and undergoes conformational changes that consequently start the fusion protein
activity [53]. However, it is also critical to note that for HMPV and RSV, despite the
overall conserved architecture with other paramyxo- and pneumovirus attachment
proteins [53], G is not required for infection to occur in cell culture and in an animal
model [56, 57]. To that, Chang and Dutch also detail five roles the attachment
protein may have in triggering the fusion protein, either by direct interaction with
the attachment protein, or through interactions with F and its own cell surface
receptor [46].

4

The small hydrophobic protein
The SH gene is expressed by a select number of NNS RNA viruses such
as PIV5, HMPV, RSV, mumps virus (MuV), J paramyxovirus (JPV), and Tupaia
rhabdovirus (TRV). Despite SH being present in all primary isolates in HMPV for
example, SH deletion is neither beneficial nor detrimental for entry, replication, or
spread in the cell culture and animal models that have been examined [50]. For
RSV and HMPV, SH forms higher order structures, can localize to the plasma
membrane, and is shown to increase plasma membrane permeability [50, 51].
Additionally, RSV SH forms non-selective cation channels that are permissive to
Na+ or K+ [51]. These data present SH as a potential viroporin.
Studies have also reported that SH regulates cytopathic effects (CPE) in
PIV5. A recombinant PIV5 virus lacking the SH gene showed an increase in TNFα-induced apoptosis, suggesting that SH inhibits apoptosis and consequent CPE
in infected cells [58]. Indeed, further research in RSV also suggest similar functions
of SH in preventing virus-induced apoptosis as a host immune response, though
these studies did not directly implicate TNF-α [51], pointing to perhaps multiple
pathways by which SH acts to protect against CPE and sustain infection in intact
cells. Surprisingly, HMPV SH has been shown to co-immunoprecipitate with F, and
drastically suppress the fusion activity in fusion reporter system [50].
The fusion protein
Although paramyxoviruses typically couple receptor binding with host cell
membrane fusion at the plasma membrane [46], the pneumoviruses HMPV and
RSV can enter cells through clathrin-mediated endocytosis, or through induction
macropinocytosis of the full viral particle [56, 59-61]. For some strains the HMPV
F protein is triggered by low pH within endosomes (Figure 1.2). For these viruses
the triggering of the fusion protein is nuanced: even though the post-fusion form is
energetically favored, F mainly exists on cell surfaces in the pre-fusion form,
suggesting an intricate balance in maintaining prefusion conformation until
productive triggering can occur. Indeed, as previously described, the attachment
protein may interact with the fusion protein, and as it attaches to host cells, could
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change the F protein microenvironment to start a cascade of events that trigger
the fusion protein. Alternatively, F may bind its own receptor, and act
independently of G, as is shown for HMPV and RSV.
Paramyxo- and pneumoviruses, are synthesized as inactive F0 forms,
folded into homotrimers within the endoplasmic reticulum (ER), and trafficked to
the plasma membrane. For PIV5 F activation, furin cleaves F0 within the trans Golgi
network (TGN) while F traverses the endocytic pathway before it is expressed on
the cell surface in the disulfide-linked fusogenically active form, F1 + F2. In other
cases, such as with HeV and NiV, F0 is first expressed on the cell surface, then is
signaled to be endocytosed and cleaved by cathepsin L in the early endosomes
and returned to the plasma membrane to mediate fusion. HMPV F can be cleaved
by TMPRSS2, HAT, matriptase, KLK5, and trypsin in cell culture [62, 63] (Figure
1.3). Even after proteolytic cleavage, F1 + F2 is maintained in a metastable
conformation until it is triggered to undergo dramatic, essentially irreversible
conformational changes into a more energetically stable post-fusion conformation.
These large conformational changes are coupled with merging the viral and host
cell membrane, thereby reducing the activation energy required to merge the
membranes and create a fusion pore. The fusion pore is subsequently expanded
to allow for the mixing of viral and cellular contents (Figure 1.4).
F proteins are class I fusion proteins that form homotrimers. Each monomer
contains a fusion peptide FP, heptad repeats A and B (HRA and HRB), a singlepass transmembrane domain (TMD), and a cytoplasmic tail (CT) (Figure 1.3). With
the help of a trimeric coiled-coil domain (GCNt) attached to the HRB in lieu of the
TMD and CT, Yin et al. successfully crystalized the first prefusion form of a
paramyxovirus F, PIV5 F. The prefusion structure of F consists of a large globular
head domain and a trimeric coiled coil. The proteolytic cleavage reveals the FP,
which is proximal to the HRA and larger (F1) segment. The FP, HRA, and F1 + F2
form the globular head domain, and it is supported by the HRB which forms the
trimeric coiled coil stalk. The TMD and CT would be immediately adjacent to the
HRB but were not present in the structure [64, 65].
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When triggered, the cleaved form of F inserts its fusion peptide into the host cell
membrane, forming a prehairpin fusion intermediate structure. With the FP being
proximal to HRA, in the transient prehairpin structure, the HRA is also released
from the globular head, stretching towards the target cell membrane. In this
intermediate structure, HRB remains pinned adjacent to the viral membrane.
Because of its unfavorably high energy state, the prehairpin intermediate
subsequently folds upon itself, driving the FP and HRA towards HRB to form a sixhelix bundle (6HB) in a hairpin post-fusion structure. This dynamic process is
hypothesized to provide the energy to merge the two membranes (Figure 1.4).
The transmembrane domain of the fusion protein
Although initially postulated to be merely a membrane anchor, the TMD of
paramyxovirus F proteins has been shown to be important in function. For
example, the TMD plays key roles in signaling for endocytosis and recycling of the
HeV fusion protein, a critical process without which F would remain fusogenically
inactive [66]. In addition, key residues within the TMD and CT tail were found to be
important for formation of virus-like particles (VLP)s. F protein cleavage alone is
not sufficient for VLP formation, as there was a clear reduction in the incorporation
of a trafficking mutant of Hendra F into VLPs when compared to the wild type (WT)
protein [67]. Moreover, replacement of Newcastle disease virus (NDV) F TMDs
with TMDs from other closely related viruses resulted in fusion-dead proteins that
could no longer associate with their homotypic attachment protein. For NDV, the
specific TMD sequence is an important factor in maintaining the structural integrity
of the fusion protein [68]. Furthermore, a study of RSV F revealed that the TMD is
important for localizing the protein onto the apical surface in polarized epithelial
cells [69].
A 2005 study of the hPIV3 fusion protein revealed that removal of the TMD
resulted in the formation of a 6HB and the isolation of F in the post-fusion
conformation [64]. This unexpected finding suggests that the TMD is important in
maintaining the metastable pre-fusion conformation of the F protein. However,
when replaced with the GCNt trimerization, the same group was able to stabilize
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PIV5 in its pre-fusion form [65]. In fact, when isolated, the TMD of PIV5 F, HMPV
F, and HeV F associate in a monomer-trimer equilibrium [70]. Moreover, when the
proximal HRB was added to the TMD of HeV F, the TMD-TMD interactions were
weakened [71], suggesting that the TMD important for maintenance of the fusion
protein trimer. Solid-state NMR and SAXS data have been used to generate a
model of the TMD structure. In this model, for each monomer, there is a helical
coiled coil which is flanked by two β-strands, creating a stand-helix-strand. The βstrand termini are suggested to be critical for inducing membrane curvature and
advancing fusion, whereas the α-helical segment of the TMD is rich in β-branched
residues, which are important to drive trimeric interactions [72, 73].
The transmembrane domain leucine/isoleucine zipper
To understand the mechanisms through which TMDs support trimeric
association of fusion proteins, an analysis of 19 paramyxoviruses yielded 140
TMDs which contained β-branched residues in a heptad repeat pattern.
Specifically, a leucine/isoleucine (L/I) zipper was found in the TMDs of several
paramyxo- and pneumoviruses, including HeV, PIV5, HMPV, and RSV, among
others. Further studies demonstrated that for HeV F, the TMD is important for
surface and total expression, stability, and fusogenic activity of the fusion protein.
These data indicate that within the TMD, the L/I zipper is an important association
and functional domain for HeV F activity. Indeed, when analyzed in isolation, the
L/I zipper was found to be an important driver of trimeric association— F proteins
lacking the TMD L/I zipper were found to have a greatly reduced trimeric
association compared to the wild type protein [74], suggesting a likely mechanism
through which the L/I zipper contributes to stabilizing the trimeric metastable
prefusion protein.
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The matrix protein of NNS RNA viruses
Even at early stages during infection, the matrix protein interacts with viral
proteins and host key host factors to facilitate viral entry. Recent literature indicates
that as early as between 6-12 hours post-infection, the HMPV genome is actively
transcribed into mRNA, in the process termed transcription, which is then used as
a template to generate viral protein [75]. At the same time, the HMPV negative
sense genome is used as a template to create a positive sense RNA antigenome,
which, unlike mRNA, is it not capped and polyadenylated., The L protein uses this
antigenome as a template to generate more negative sense viral genomic RNA
(vRNA) [35, 75], a process known as replication. These viral replication and
transcription events occur in punctate structures within the cytoplasm termed
inclusion bodies, viral factories, or in the case of rabies virus, Negri bodies [76-80].
For the HMPV, inclusion bodies coalesce in an actin-dependent manner and are
important for efficient viral replication and translation [75]. Importantly, the M
protein can interact with N, and consequently with the RNP, as well as with the
cytoplasmic tails of F and G, which allows M to recruit RNPs to the plasma
membrane for assembly into viral particles [44]. Furthermore, for many viruses,
the M protein alone can form authentic looking virus-like particles (VLPs),
suggesting that it plays a critical role in viral morphogenesis [44, 81, 82] (Figure
1.5 and Figure 1.6).
The general architecture of matrix proteins across Mononegavirales
Figures 1.7 and 1.8 show that despite the low sequence conservation
across the family, there is a degree of sustained structural similarity, suggesting a
possible convergent evolutionary relationship that would explain similarity in their
function during their respective life cycles. For paramyxoviruses, even though the
primary M protein sequences are not conserved, studies show that their structures
are similar, with two characteristic orthogonal β-sandwiches, flanked by α-helices.
[44, 83]. Importantly, Chatterjee et al. discovered that the NS1 protein of RSV,
which is a strong inhibitor of transcription and replication [84] as well as a potent
suppressor of the innate immune response [85], bears a β-sandwich structure that
is very similar to that of M [86].
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Structural plasticity is important for the function of pneumovirus matrix
proteins
In infected cells, paramyxovirus M forms an ordered layer on the
cytoplasmic side of the plasma membrane [44], and HMPV M interacts with the
membrane through its concave surface [83, 87]. The EBOV matrix cognate VP40
contains a hydrophobic patch that inserts into the plasma membrane. In addition,
VP40 contains a positively charged domain which selects for plasma membrane
phosphatidylserine (PS). Although VP40 traverses to the membrane as a dimer,
after association of PS it forms a higher order filamentous oligomeric structures
that induce membrane curvature [81]. Similar to EBOV M, HMPV and RSV M exist
in a dimeric form but also oligomerize to form filaments in the presence of lipids
[83, 88]. Interestingly, Leyrat et al. have shown that the N-terminal domain of
HMPV contains a high affinity Ca2+-binding site, a feature that has not been
reported for other viral M proteins. When HMPV M binds Ca2+, it induces a 25⁰C
increase in melting temperature, likely increasing the structural rigidity, thereby
possibly contributing the structural stability of matrix oligomers for more efficient
budding facilitated by the M protein [83].
Nuclear entry of some NNS RNA viruses
With exception of Bornaviridae, NNS RNA viral replication and transcription
is well-documented to occur in the cytosol. Curiously, despite this, several reports
show that the matrix proteins of NNS RNA viruses including Newcastle disease
virus (NDV), vesicular stomatitis virus (VSV), Sendai virus (SeV), as well as
Hendra (HeV) and Nipah virus (NiV) are trafficked to the nucleus during the
infectious cycle [89]. This nuclear entry is unlikely to result from free diffusion of
the protein through the nuclear pore, since most matrix proteins exist dimers or
higher order structures that exceed the 50kDa upper limit to passively traverse the
nuclear pore complex [82, 83, 87, 88, 90, 91]. Instead, for some viruses such as
NiV M, there is a bipartite nuclear localization sequence which is recognized by
importin-α that regulates nuclear entry and a well-documented nuclear export
signal (NES) [90], pointing to a role for nuclear entry or sequestration.
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Unlike most viruses that belong to the mononegavirales order, Borna
disease virus (BDV) is well-documented to have a nuclear step in viral replication.
As reviewed by Honda et al., like other NNS RNA viruses, BDV M binds to viral
RNPs [92, 93]. Interestingly, the group discusses results which demonstrate that
BDV M binds to and facilitates the nuclear to cytoplasmic shuttling of the BDV
RNPs, better orienting them for assembly [93]. Given this observation, and given
that BDV M is very similar to the N terminal domain of EBOV VP40 [94], it is
possible that the other NNS RNA viruses that do not require a nuclear step during
replication have a conserved evolutionary step in maintaining the nuclear sojourn,
but in this case with M only; however, since viruses evolve to fine-tune their protein
functionalities, and since distinct roles for nuclear entry have been outlined for
certain viruses such as NiV and RSV [90, 95], it is unlikely that other NNS RNA
viral matrix protein nuclear import is completely benign. It is however important to
note that not all NNS RNA viral matrix proteins have a nuclear step during infection.
Matrix nuclear entry supports modification for intracellular signaling,
oligomerization, or membrane association.
While within the nucleus, SeV M and NiV M are modified by ubiquitin. The
ubiquitin modification on NiV occurs on a critical lysine residue, K258, within the
NLS. Replacing K258 with arginine, which maintained the positive charge and thus
allowing nuclear entry but not the ability to be ubiquitinated, led to an accumulation
of NiV K258R M in the nucleus, resulting in a dramatic reduction in viral budding
and spread [89]. It is tempting to assume the reduced cytoplasmic levels of K258R
M available after nuclear accumulation was the sole determinant of this reduced
budding and spread. However, when nuclear import of NiV M was blocked
altogether with a K258A mutation, NiV K258A M was only present in the cytosol,
but did not associate with membranes.
To further understand the role of ubiquitin in NiV M membrane association,
the authors created a NiV K258R M-ubiquitin fusion protein. This fusion protein
allowed M to be duly imported to the nucleus but prevented ubiquitination at the
K258 position specifically. Here, the ubiquitin fusion rescued the nuclear
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accumulation phenotype and allowed export of protein, despite the K258R
substitution. While it was expected that the ubiquitin-rescued K258R mutant would
result in plasma membrane localization, notably, this mutant also failed to localize
at the membrane [89, 90, 96]. The authors therefore speculated that either both
the K258A and the K258R-ubiquitin NiV M mutants block interaction with important
host factors that normally allow for additional post-translational modifications that
functionalize M or that ubiquitination regulates both the oligomerization interface
and the membrane interaction of M, allowing it to form the characteristic helical
filamentous ordered layer underneath the plasma membrane [89, 90].
Nevertheless, these data also suggest that majority of newly synthesized M
relocates to the nucleus providing more evidence to suggest a nuclear function
during infection. While the ubiquitination of M has only been documented for
certain paramyxoviruses, it does not exclude the possibility that other posttranslational modifications may occur which are not specific to the nucleus. These
data also beg the question of why this specific modification must happen in the
nucleus, with the abundance of E3 ligases in the cytosol.
Matrix protein nuclear localization allows for interaction with splicing
machinery
Studies show that for the paramyxoviruses SeV, MuV, NiV, and HeV, in
addition to localizing to the nucleus, M is specifically imported to the nucleolus [89].
For these paramyxoviruses, immunofluorescence studies revealed that both WT
and the aforementioned K258R mutation result in localization within the nucleolus;
however, the K258R mutant accumulated within the nucleolus to a higher degree
than WT. These studies showed that NiV M is detected within the nucleus as early
as between 8 and 16 hpi, primarily within punctate structures consistent with the
nucleolus [96]. It is currently unclear the mechanisms behind the nucleolar
targeting of paramyxovirus matrix proteins. However, biochemical studies support
this nucleolar association, as NiV M was shown to interact with upstream binding
factor F (UBF), a transcription factor particularly associated with recruiting
nucleolar factors [89].
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In addition, RSV M and HeV M have been associated with the nucleolar
protein nucleophosmin (Npm) B23 [97, 98]. UBF and Npm B23 are known to be
associated with ribosomal proteins, and thus may suggest a role between matrix
proteins and ribosomal biogenesis [98]. The nucleolus is the hub of ribosomal
biogenesis [99], which may suggest the role of several NNS RNA viral matrix
participation in co-opting host translational responses; however, the nucleolus also
serves as a central processing unit of stress response [99]. Similarly to nonmembrane-bound cytoplasmic units such as stress granules, P-bodies, and viral
inclusion bodies, it is possible that the nucleolus undergoes liquid-liquid phase
separation (LLPS) in response to variable cellular environments (such as stressors
associated with heat shock, viral infection, or protein aggregation).
Furthermore, not only was fibrillarin, a nucleolar protein found to be critical
for Henipavirus infection, but also, specifically, methylation of fibrillarin is essential
for viral RNA synthesis. Thus, fibrillarin may be important in proviral RNA synthesis
mechanisms and its association with pre-ribosomes and NOP56 or NOP58 [100]
could point to methyltransferase activity of host nucleolar enzymes being of
particular importance to certain NNS RNA viral infections. These may suggest a
novel druggable target. These findings may not exclude the idea that the matrix
protein may also in fact interact with other ribosomal biogenesis machinery to
prevent targeting of other important host cellular proteins form being synthesized.
It is possible M also associates with hnRNPs, and other spliceosome machinery.
Nuclear matrix protein usurps critical cellular processes
Viral infections notably co-opt cellular processes for their own proliferative
benefit. Earlier studies showed that VSV M is instrumental in rapidly shutting down
host cell macromolecular synthesis including mRNA and proteins. Experiments
showed, that independent of other viral proteins, VSV M has profound inhibitory
effects on host cell-directed mRNA and snRNA synthesis [101, 102]. This inhibitory
role of M is also genetically distinct from its canonical roles in viral assembly and
budding [103]. Upon further investigation, the nuclear import of VSV M was found
to directly influence RNA species that specifically needed to be transported across
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the nuclear pore complex (NPC) [101], alluding to a role for M in mediating
nucleocytoplasmic shuttling of host macromolecules. Indeed, the presence of M in
Xenopus laevis oocytes highly mimics Ran-GTPase deficiency, and thus was
hypothesized to interfere with Ran-GTPase-dependent nucleocytoplasmic
shuttling [104].
Nuclear entry of matrix protein supports immune modulation
Unlike RSV, HMPV does not have the NS1 and NS2 proteins, however it is still
pathogenic. Evidence suggests that while sequence conservation is low, the
secondary structures of RSV NS1 and RSV M are similar: NS1 resembles one half
of the orthogonal beta sandwich that constitutes the RSV M protein. When
compared, RSV NS1 showed a high degree of alignment with the N-terminal
domain of RSV M (RMSD 3.78 Å over 96 residues). Moreover, RSV NS1 is also
structurally similar to EBOV VP40 and Newcastle disease virus (NDV) M despite
low sequence similarities. Based on their data, Chatterjee et al. speculate that a
potential duplication event of the N-terminus of M gave rise to the NS1 protein,
which then divergently evolved its functions in immune modulation [86]. These data
suggest a conserved functional significance in the structural fold of the NS1 and
some NNS RNA M proteins. NS1 is a potent immunomodulator; however, most of
its reported function is in facilitating inflammatory responses, IFN antagonization,
and inhibition of dendritic cell maturation arise from the C terminal α-helix, which
is the portion of the RSV NS1 structure that differs from HMPV M.
The matrix protein regulates viral transcription and translation
Transcription
Matrix proteins of NNS RNA viruses play important roles in regulating
transcription and replication of viral genomes: BDV, rabies virus (RV), and measles
virus (MeV), matrix proteins inhibit viral transcription. For these viruses, M binds to
and condenses viral RNA, making it less accessible as a template for transcription
[94, 105, 106]. Curiously, for RV, as M inhibits viral transcription, it performs an
opposite stimulatory role in replication [105]; providing insight into how
transcription and replication are balanced during infection.
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Further work on RV M pinpointed residue 58 as important in interacting with
the viral polymerase and consequently on downstream effectors that facilitate the
switching viral transcription-viral replication gradient. Importantly, this data
highlight that mutations at residue 58 do not affect assembly and budding, further
elucidating a distinct role of M outside of the classical budding and egress [107].
In terms of regulation, it is hypothesized that because transcription and consequent
translation of viral proteins is prioritized upon entry since genomes require
encapsidation [32, 34-36], a critical concentration of matrix protein in the cytosol
would inhibit transcription. This inhibition of transcription may allow the viral
polymerase to favor replication of the viral genome. Indeed, nuclear sequestration
of M coincides with an increase in mRNA production and nuclear exit is consistent
with decreased mRNA for RSV [87, 95, 108].
Replication
Interestingly, studies on EBOV, MeV, and RSV suggest that increasing
amounts of M is detrimental for viral replication.

Viral reporter gene assays

suggest that in the presence of increasing M, there is a correlative decrease in
viral replication [95, 106, 109]. Like with the transcription model, this may point to
a role for sequestration of M in the nucleus to allow for an increase in viral
replication. It is not far-fetched to postulate such a mechanism would result in the
gradual cessation of viral replication at the time that M is also gradually exported
from the nucleus to prepare nascent virions for assembly.
This phenomenon also applies to influenza A virus, which belongs to the
family Orthomyxoviridae, an RNA viral family whose genomes are encoded in
multiple segments. Influenza A has an obligate nuclear stage and a matrix cognate
which supports viral transcriptase negative regulation [110]. It is possible that this
is an evolutionary or functionally conserved function. Moreover, the presence of M
may mark the beginning of assembly, and its nuclear shuttling sequesters M away
while replication occurs exponentially. Interestingly, unlike other NNS RNA virus
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counterparts, there is currently no evidence that Henipa matrix proteins affect viral
replication and transcription, despite being trafficked to the nucleus [89].
The unique calcium binding site of HMPV M
In 2014, Leyrat et al. published the crystal structure of HMPV M, which was
surprisingly found to have a calcium binding site [83] (Figure 1.7).They found that
calcium (Ca2+) had a role in the structural stability of M, and also speculated on
whether this Ca2+ association plays a role in the contacts between M and N,
possibly influencing which point in the viral life cycle assembly occurs [83].
Furthermore, reports show that RSV M is translocated into the nucleus during
infection, and the function of this sojourn is currently unknown [95, 111]. However,
RSV M is known to contain RNA-binding properties [112], and this may modulate
interactions with host cell nucleic acids. Compared to mammals, viruses such as
HMPV and RSV have a relatively small proteome, encoding 9 and 11 proteins
respectively [9, 113]. However, there are still many functions involving viral
proteins and the viral genome within infected cells that are not yet well understood.
Calcium signaling may be important component in viral spread
Ca2+ plays important roles in paramyxo- and pneumoviral infection and
spread. For example, in the absence of Ca2+, RSV infectious virus yield was slightly
reduced, and cell fusion and syncytium formation was ablated [114]. Another study
corroborated this observation that RSV requires Ca2+ for efficient spread in cell
culture [115]. In addition, when exposed to low Ca2+, production of SeV was
suppressed in infected LLC-MK2 cells. Furthermore, Ca2+ was found to be critical
for cell surface expression of SeV glycoproteins. In low Ca2+ conditions, viral
glycoproteins were accumulated within the Golgi. When normal Ca2+ conditions
were restored, the otherwise accumulated SeV glycoproteins, cell surface
expression of SeV glycoproteins was quickly rescued, and consequently, Sendai
virion production was restored [116].
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Calcium binding may support conformational changes that could allow for
membrane association, oligomerization and/or fortification of the viral
capsule.
Amarasinghe and Dutch discuss the possibility that Ca2+ binding leads to
additional conformational changes within HMPV M that potentially regulate
interactions with (a) host or viral factor(s). Although M interacts with the plasma
membrane through its highly positively charged CTD, it is possible that Ca2+
binding at the NTD would lead to conformational changes that could extend to the
CTD to potentially affect membrane association, as well as the interactions of M
with the CT tails of the surface glycoproteins. Moreover, if Ca2+ binding in HMPV
M affects protein-protein and/or protein-lipid interactions, then it is likely that viral
infection may regulate the intracellular Ca2+ environment to favor viral infection
[117]. Indeed, the ability of HMPV M to bind Ca2+, and the consequent induction of
increased thermostability suggest that Ca2+ plays roles in stabilizing viral particles
as they traverse the Ca2+-rich extracellular environment. This phenomenon may
confer an advantage in the lifespan of the virus. [83]. Additionally, since the Ca2+
binding site faces away from the membrane, there is a possibility that variations in
Ca2+ concentrations inside infected cells at various stages of the viral cycle
regulate the assembly of viral nucleocapsids onto M arrays at viral budding sites;
but there is also a possibility of its involvement in intracellular transport of M
proteins to the membrane [83].
Dissertation overview
The current COVID pandemic brings to light the devastation that relatively
small biological entities such as viruses can wreak on the global population. Even
so, concerted advancements in science to generate world-saving vaccines
highlight how critical viral research is. NNS RNA viruses are major contributors to
emerging viruses, pinpointing the specific need to dissect their mechanisms of
infection. Events that lead to successful entry, replication, transcription, and spread
of viral agents are important in the understanding and identification of novel
therapeutic targets. Moreover, understanding the mechanisms of viral infection
can also provide more insight into non-pathogenic cellular processes, allowing for
the progress of basic science. Keeping the broader impact of our basic research
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in mind, the Dutch lab studies the fusion, entry, establishment of infection, and
egress of paramyxo- and pneumoviruses, two families containing pathogens of
worldwide importance. For the fusion studies, we focus on the biochemistry and
biophysical properties of the main fusion catalyst, the fusion (F) protein. My work
focuses on PIV5 F, a model paramyxovirus. Our work on established infection
focuses on unique mechanisms to which cells react to viral pathogens. In addition,
I have studied the HMPV matrix (M) protein to dissect its roles in progression of
infection.
HMPV and PIV5 are enveloped viruses, and as such need to undergo the
energetically unfavorable process of merging their membranes with host cells
before they can successfully infiltrate them. For these viruses, this process
requires the fusion protein. Fusion proteins have been extensively studied, and
much of their mechanisms of action can be detailed; however, there are still
significant gaps in the field that warrant further research. For example, paramyxoand pneumovirus fusion protein transmembrane domains were initially thought to
solely be membrane anchors. However, studies showed that when removed or
replaced, major changes in the folding and/or oligomerization of the rest of the
protein occurred, suggesting more critical roles of the transmembrane domain in
fusion function. Indeed, in isolation, the transmembrane domain of PIV5, HMPV,
and HeV F are able to associate in trimeric form, indicating that the transmembrane
domains also play roles in trimerization of full proteins.
Additionally, an interesting phenomenon that occurs with viral fusion
proteins is that they exist largely on the cell surface in a metastable pre-fusion form
until the “trigger” for fusion occurs, allowing them to rearrange into a more
energetically stable post-fusion conformation. While much is known about the
conformational processes that occur with the fusion protein, much more work is
needed to elucidate what maintains the metastable pre-fusion conformation. The
Dutch lab has done previous work in identifying potential association motifs within
the fusion protein transmembrane domain for a multitude of paramyxo- and
pneumovirus fusion proteins. This work identified a heptad repeat of
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leucine/isoleucine residues that were important for trimerization and fusion
function of the HeV fusion protein. To build on these findings, in chapter 3, I
address the functional relevance of the leucine/isoleucine zipper by testing
whether it is important for another paramyxoviruses. Based on the works described
in this chapter, I hypothesized that the transmembrane domain L/I zipper would be
critical in the expression, turnover, and functionality of the PIV5 fusion protein. To
address this hypothesis, I used the model system PIV5 to address the expression,
fusion, and stability in the context of a mutated leucine/isoleucine zipper. Our data
show that unlike with HeV fusion protein where expression is reduced, PIV5 fusion
protein expression is maintained, while fusogenic activity is ablated.
While studying the effects of actin on cytoplasmic inclusions with Dr. Nicolás
Cifuentes-Muñoz, a former post-doctoral scholar at the Dutch lab, I became
interested in the HMPV matrix protein. The matrix protein is a key element in viral
assembly as it forms an ordered layer underneath the viral membrane, acting as a
scaffolding protein allows the virus to bud and form viral particles which egress
from host cells. In addition, matrix proteins are known to have important contacts
with the RNP, as well as the cytoplasmic tails of the surface glycoproteins,
orienting them with each other for efficient viral assembly.
Although the vast majority of NNS RNA viral replication occurs in the
cytosol, with no apparent roles for viral proteins within the nucleus, I noted that
HMPV M indeed makes a nuclear sojourn. This is consistent with several other
viral systems including the matrix proteins of the deadly HeV and NiV viruses. In
chapter 4, I discuss the timing of nucleocytoplasmic transport, and address
hypotheses involving the sequestration of the matrix protein within the nucleus at
the heights of viral infection. Our work shows that when the matrix protein is
knocked down with a peptide-conjugated phosphorodiamidate Morpholino
oligomer (PPMO), inclusion body morphology and placement are perturbed.
Importantly, we find that a lack of the matrix protein results in a drastic reduction
in viral transcription and replication, with the mRNA of all viral proteins being
remarkably reduced, and the translation of a representative protein also severely
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hindered. Our results represent a novel finding that M early in infection is important
in both transcription and replication of HMPV.
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Figure.1.1 The parainfluenza virus 5 particle, a prototypical paramyxovirus.
A. The non-segmented negative sense NNS RNA genome is encapsidated by
nucleoprotein (N), along with the polymerase complex that consists of the
phosphoprotein (P) and the large protein (L). These altogether form the
ribonucleoprotein complex RNP. The RNP is protected by a host derived
membrane, studded with the fusion protein (F), the attachment protein with
hemagglutinin and neuraminidase activity (HN), and the small hydrophobic protein
(SH). The PIV5 genome also encodes the nonstructural protein (V) an immune
response agent. B. The genomic arrangement of PIV5.
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Figure 1.2 The diversity of entry of paramyxo- and pneumoviruses.
After engagement with a cell surface receptor or attachment factor, entry may
occur by merger of the viral membrane with the plasma membrane at the cell
surface (A), endocytosis of the full viral particle, where low pH within endosomes
triggers membrane fusion (B), macropinocytosis, with the particle passing through
the endocytic pathway into low pH endosomes before fusion occurs (C).
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Figure 1.3 Cleavage of the fusion protein.
The fusion protein is initially expressed in a fusogenically inactive form F0 (top).
For PIV5, the protein is cleaved within the trans Golgi network by furin into the
fusogenically active disulfide-linked F0+F1 (bottom). For other viruses, F can be
cleaved by cathepsin L within low pH endosomes, or once incorporated into viral
particles or when on the cell surface by extracellular matrix proteases such as
matriptase. The fusion protein consists of the F1 and F2 subunits (dark teal), the
fusion peptide (FP, yellow), heptad repeat A (HRA, orange), heptad repeat B
(HRB, light teal), the transmembrane domain (TMD, blue), and the cytoplasmic
tail (CT, white)
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Figure 1.4. Conformational changes that occur during fusion.
Before signaling to begin the fusion process occurs, the fusion protein is held in a
metastable prefusion conformation (A). As fusion is initiated, the fusion peptide
inserts into the host cell membrane, extending the adjacent heptad repeat A region
towards the host cell to form a prehairpin intermediate (B). Finally, the prehairpin
intermediate folds upon itself, with the heptad repeats A and B forming a six-helix
bundle and merging the viral and target cell membrane (C). This schematic shows
two adjacent fusion proteins, providing the two-dimensional view of a fusion pore.
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Figure 1.5. The human metapneumovirus particle.
A. Schematic of a HMPV viral particle. The host-derived membrane of the
pneumovirus is studded with multiple copies of the fusion protein (F), attachment
protein (G), and small hydrophobic protein (SH). Directly underneath the
membrane is an ordered layer of matrix proteins (M). The core of the virus consists
of the ribonucleoprotein complex, composed of the nucleoprotein (N), which
encapsidates

the

negative

stranded

single

sense

RNA

genome,

the

phosphoprotein (P), and the large protein (L), which is an RNA dependent RNA
polymerase. The M2 gene encodes two additional proteins (M2-1 and M2-2), which
play roles in polymerase processivity and immunomodulation. B. The arrangement
of the human metapneumovirus genome.
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Figure 1.6.The human metapneumovirus life cycle.
Entry is initiated when the viral glycoproteins engage cell surface receptors (1).
The viral particle is then endocytosed (2), where fusion occurs in low pH
endosomes (3). As the genome is released, transcription (4) and replication (5)
occur in discrete unenveloped compartments within the cytosol termed inclusion
bodies. Following transcription, viral mRNA are exported from inclusion bodies,
where they gain access to ribosomes to be translated (6). Following translation,
the matrix protein is promptly delivered into the nucleus. The matrix protein can
shuttle between the nucleus and cytoplasm (7). After the cell surface glycoproteins
traverse the secretory pathway, the matrix proteins assemble them with viral RNA
along with additional viral proteins. These assembled proteins bud into viral
particles (8) and are released (9), prime for infection of other cells. In addition to
release of nascent viral particles, HMPV induces the formation of extensions that
can carry viral genomes from cell-to-cell.
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Figure 1.7. Sequence and structure-based relationships of Mononegavirales
matrix proteins.
The relationships of mononegavirales matrix proteins based on (top) sequence
similarity and (bottom) structure similarity. Top The evolutionary history was
inferred using the Minimum Evolution method. The optimal tree is shown. The tree
is drawn to scale, with branch lengths in the same units as those of the evolutionary
distances used to infer the phylogenetic tree. The evolutionary distances were
computed using the Poisson correction method and are in the units of the number
of amino acid substitutions per site. The ME tree was searched using the CloseNeighbor-Interchange (CNI) algorithm at a search level of 1. The Neighbor-joining
algorithm was used to generate the initial tree. This analysis involved 13 amino
acid sequences. All ambiguous positions were removed for each sequence pair
(pairwise deletion option). There were a total of 383 positions in the final dataset.
Evolutionary analyses were conducted in MEGA X. Bottom: Structural similarity
dendrogram. The dendrogram is derived by average linkage clustering of the
structural similarity matrix (Dali Z-scores).
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Figure 1.8. Similarity matrix heatmaps of Mononegavirales matrix proteins
based on sequence and structural identity.
Top: Sequence identity matrix generated in ClustalW2 and (bottom) structural
identity matrix generated by DALI server based of matrix proteins as represented
in Figure 1.7
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Figure 1.9. The human metapneumovirus matrix protein has a calcium
binding site.
Crystal structure of the HMPV matrix protein (right) showing residues that
coordinate calcium binding (Glu 24, Asp 26, Leu 28, Lys 101). The diagram shows
an adjacent Glu 103 that has not yet been shown to support calcium binding.
Calcium shown in green. PDB code:4LP7
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Chapter 2 : MATERIALS AND METHODS
PIV5 F Transmembrane domain project
Cell lines and culture
Vero cells were acquired from American Type Culture Collection (ATCC). BSR
cells were kindly provided by Karl-Klaus Conzelmann (Max Pettenkofer Institute),
and BSR/T7 cells made by constitutively expressing T7 polymerase in BHK cells
[118] The cells were maintained in Dulbecco’s modified Eagle’s media, DMEM
(Invitrogen), supplemented with 10% fetal bovine serum, FBS (Sigma). BSR cells
were additionally maintained on 0.5 mg/mL of geneticin (Gibco) every third
passage, to maintain selection of T7 polymerase.
Plasmids and antibodies
Plasmids with the PIV5 F or HN (W3A) were kindly provided by Robert Lamb
(Howard Hughes Medical Institute, Northwestern University) and Hendra F or Gcontaining plasmids were generously provided by Dr. Lin-Fa Wang (Australian
Animal Health Laboratory). Mutants for the study were created using the
QuikChange site-directed mutagenesis kit (Stratagene) in pGEM , and subcloned
into the eukaryotic expression vector pCAGGS [119], for expression in Vero and
BHK cells. For all the analyses, lipofectamine plus and plus reagent (Thermo
Fisher) were used per manufacturer’s instructions. All constructs used were
sequenced (ACGT) to ensure sequence integrity. For PIV5 F analyses, the
cytoplasmic tail antibody, which detects residues 516-529 was used, and to detect
pre-fusion PIV5 F species, mAb F1a kindly provided by Dr. Richard Randall
(University of St. Andrews) were used. HeV F 5G7 antibodies were kindly provided
by Dr. Chris Broder (Uniformed Services University of the Health Sciences).
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Immunofluorescence
Cells were seeded in 8-well chamber labtek plates (Thermo Fisher) to be at
approximately 60-70% confluency for the next day. The following day, cells were
transfected with 0.75μg of pCAGGS-MCS, pCAGGS-PIV5 F WT, or pCAGGSPIV5 F LIZ; pCAGGS-HMPV F WT or pCAGGS-HMPV F LIZ; and pCAGGS-HeV
F WT or pCAGGS-HeV F LIZ. 24 hours post-transfection, cells were fixed in 4%
paraformaldehyde (PFA) for 20 mins at room temperature, followed by
permeabilization in 1% Triton X-100 for 15 mins at 4°C. Cells were then blocked in
1% normal goat serum (NGS) in phosphate buffered saline (PBS), followed by
incubation with their respective antibodies overnight (mAb F1a for PIV5 F, and anti
HeV F 5G7 for HeV F) at 4°C. The next day, cells were washed seven times with
0.05% Tween 20 in PBS, and incubated with FITC-conjugated secondary
antibodies at 1:300 in 1% NGS for 1 hour at 4°C. The cells were washed again
seven times with 0.05% Tween 20 in PBS, before being mounted with
VECTASHIELD antifade mounting media with DAPI (Vectorlabs). Images were
taken using a Nikon A1 confocal microscope and analyzed with NIS-Elements
software. Images were processed with Adobe Photoshop with equivalent
adjustments made to all channels.
Time course radioimmunolabel assay
Subconfluent Vero cells were transfected with 2.5 μg of pCAGGS-MCS, pCAGGSPIV5 F WT or pCAGGS PIV5 F LIZ in 6-well plates. The next day cells were
washed twice with PBS and starved for 45 min at 37°C in cysteine-methioninedeficient DMEM. Following the starve, cells were labeled for 30 minutes with
Tran[35S] metabolic label (100 μCi/mL; MP Biomedicals). Following the label, cells
were washed twice with PBS and normal DMEM was replenished on cells. At the
indicated time points, the cells were washed three times with PBS and lysed with
radioimmunoprecipitation (RIPA) lysis buffer (100 mM Tris-HCl, pH 7.4, 150
mM NaCl,

0.1%

SDS,

1%

Triton

X-100,

1%

deoxycholic

acid,

1

mM phenylmethylsulfonyl fluoride (Sigma), and 25 mM iodoacetamide (Sigma)).
Lysates were collected and centrifuged at 136,500 × g for 15 mins at 4°C, and the
supernatants collected for subsequent analysis. 8 uL of anti PIV5 F cytoplasmic
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tail antibody 516-529 was added to each cleared lysate and incubated for three
hours at 4°C with rocking. Antibody-conjugated PIV5 F in the lysate was
immunoprecipitated with 30 µL of Sepharose-A beads (GE Healthcare) for 30
minutes at 4°C with rocking. Following the incubation, lysates were washed twice
with RIPA + 0.30 M NaCl, twice with RIPA + 0.15 M NaCl, and once with SDS
wash II (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 2.5 mM EDTA). 30µL of 2X SDS
loading buffer was added to each sample and boiled for 10 minutes. Samples were
run on 15% SDS-PAGE gels, dried, and exposed to a Phosphor screen for three
days. The phosphor screens were visualized using the Typhoon imaging system
(GE Healthcare). To quantify bands for analyses, band densitometry (ImageQuant
5.2) was used. Total protein expression was determined as the sum of the
uncleaved F0 plus the cleaved larger F subunit, F1
Surface biotinylation
Vero cells were seeded in 60mm dishes to be approximately 80% confluent for the
next day. The following day, cells were transfected with 4.0 μg of pCAGGS-MCS,
pCAGGS-PIV5 F WT or pCAGGS-PIV5 F LIZ with lipofectamine plus and plus
reagent (Thermo Fisher) according to manufacturer’s instruction. At 18-24 hours
post transfection, cells were washed twice with PBS, and starved for 45 mins in
cysteine-methionine-deficient DMEM. The cells were then labeled in conditioned
cysteine-methionine-deficient DMEM containing Tran[35S]-label (100 μCi/ml; MP
Biomedicals) for three hours. At this time, cells were washed three times in icecold PBS, pH 8, followed by a 35 minute biotinylation with 1mg/mL of EZ-Link
Sulfo-NHS-Biotin (Pierce) in PBS pH 8 with rocking at 4°C. The cells were then
brought to room temperature for 15 minutes and washed twice with ice-cold PBS
pH 8. Cells were lysed in 500 μL of RIPA lysis buffer, scraped, and centrifuged at
136,500 × g for 15 mins at 4°C. The supernatant was transferred to a 1.5mL
Eppendorf tube, where 8 μL of PIV5 F antibody 516-529 were added to incubate
with rocking for three hours. The fusion protein was then immunoprecipitated by
incubating with 30 μL of protein Sepharose-A beads (GE Healthcare) for 30
minutes and washed twice with RIPA + 0.30 M NaCl, twice with RIPA +
0.15 M NaCl, and once with SDS wash II. After the beads were washed, 60 μL of
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10% SDS was added, and the samples were boiled for 10 min, transferred to a
separate tube, and washes repeated with 40 μL of 10% SDS for a total of 100 μL.
10 μL, denoting 10% of the supernatant, was moved to a separate tube to be used
to analyze the total protein population. To the remaining supernatant, 30 μl of
streptavidin beads (Pierce) and 400 μl of biotinylation dilution buffer (20 mMTris
(pH 8), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.2% bovine serum albumin)
were then added for 1 h at 4°C with rocking. Streptavidin was used to label the
biotinylated surface population, which was subsequently precipitated and washed
with RIPA buffers as noted above for the total population. Samples were analyzed
with 15% SDS-PAGE and visualized using the Typhoon imaging system (GE
Healthcare). Band densitometry using ImageQuant 5.2 was performed for each
experiment to quantitate the amount of F expressed, which was calculated as the
sum of F0 and F1, normalized to WT. (Figure 2.1)
Surface expression with prefusion conformation-specific antibody: flow
cytometry
Subconfluent Vero cells were transfected with pCAGGS-PIV5 F WT or pCAGGSF LIZ using Lipofectamine plus and Lipofectamine reagent according to the
manufacturer’s protocol (Thermo Fisher). Cells were washed twice with ice cold
PBS twenty-four hours after transfection. The remainder of the experiment was
performed on ice unless otherwise indicated. After washing, transfected cells were
incubated with rocking with 1:300 of mAb F1a antibody, which detects the
prefusion form, for 1 h. Cells were subsequently washed and incubated with a
FITC-conjugated secondary antibody at 1:1000 for 30 minutes with rocking, away
from light (covered in tin foil). Cells were once again washed with PBS, lifted with
50mM EDTA in PBS for 15-20 minutes at 37ºC and then transferred to 4ºC for 3
hours. Following lifting, cells were fixed at in 2% PBS and transferred to FACS
tubes for processing at the UK flow cytometry core.
Syncytia assay
Subconfluent BHK cells in a 6 well plate were transfected with pCAGGS-PIV5 F
WT or pCAGGS PIV5 F LIZ and pCAGGS-PIV5 HN in a ratio of 1:1 for PIV5 F:PIV5
HN. Twenty-four hours after infection, cells were imaged for syncytia with a Nikon
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TS100 microscope with 10× objective. Syncytia were captured with a Nikon digital
camera attached to the microscope.
Luciferase reporter gene assay
Subconfluent Vero cell monolayers in 12-well plates were transfected with T7
promoted Luciferase plasmid, pCAGGS-PIV5 F WT or LIZ, and pCAGGS-PIV5
HN. Transfection was performed at 1:1:0.8 for F:HN:luciferase under T7 promoter.
At 24 hours post-transfection, BSR T7 cells expressing the T7 RNA polymerase
were overlaid onto the Vero cells and incubated at 37°C for 3 hours. The
monolayers were then washed twice with PBS, lysed in a luciferase lysis buffer
(Promega), and clarified by centrifugation per the manufacturer's instructions
(Promega). For each sample, lysate was loaded into a 96-well plate, where
luciferin was added at a 1:1 ratio of lysate:luciferin. Where there was successful
fusion, T7 RNA polymerase from BSR cells would gain access to and synthesize
the Luciferase mRNA under the control of the T7 promoter. Luciferase enzyme
activity was quantified in a luciferin-dependent reaction and quantified as
luminescence with a Lmax luminometer (Molecular Devices). Luciferase reporter
activity for mutants were normalized to WT. (Figure 2.2)
Thermal triggering assay
Subconfluent Vero cells in a 12 well plate were transfected with either pCAGGSPIV5 F WT of LIZ according to manufacturer’s protocol (Lipofectmaine plus and
lipofectamine reagent; Thermo Fisher). The following day, at 24 hours post
transfection, transfected Vero cells were utilized in a thermal triggering assay as
follows: for 15 minutes, cells were incubated at 4ºC, 37ºC, 55ºC, 60ºC, and 65ºC.
Cells were immediately placed on ice after thermal treatment for 15 minutes to halt
triggering, before they were prepared for flow cytometry. The rest of the procedure
was performed on ice as detailed above in the flow cytometry protocol used to
quantify surface expression of the prefusion F. The thermal triggering assay
addressed changes in expression of the prefusion conformation of F at the surface
of the cell in response to triggering with heat. (Figure 2.3)
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HMPV matrix protein project

Cell lines and culture
A549, BEAS-2B, and Vero cells were acquired from ATCC. A549 cells were
maintained in F-12 (Kaighn’s) medium (GE Healthcare), supplemented with 10%
FBS (Sigma) and 1% penicillin/streptomycin. BEAS-2B cells were grown in
bronchial epithelial cell growth medium (BEBM) supplemented with the reagents
from a BEGM SingleQuot kit growth factors (Lonza), and Vero cells were
maintained in DMEM supplemented with 10% FBS (Sigma). BSR cells were a kind
gift from Karl-Klaus Conzelmann (Max Pettenkofer Institute) and were maintained
in Dulbecco’s modified Eagle’s media (DMEM) and 10% FBS.
Plasmids and antibodies
Mutants for the study were created using the QuikChange site-directed
mutagenesis kit (Stratagene) in pGEM, and subcloned into the eukaryotic
expression vector pCAGGS [119], for expression in A549 and Vero cells. pTM1 L,
M2-1, N, P and CAT-Luciferase minigenome reporter assay plasmids for HMPV
were a kind gift from Dr. Rachel Fearns (Boston University). For all the transfection
analyses, lipofectamine 3000 (Thermo Fisher) was used per manufacturer’s
instructions. All constructs used were sequenced (ACGT) to ensure sequence
integrity. We used the conformational antibody mAb JOJ (obtained from Thermo
Fisher) for immunofluorescence experiments and conformational studies, and a
polyclonal against antibody avian metapneumovirus M protein, which also crossreacts with HMPV M, kindly provided by Sagar M. Goyal (University of Minnesota),
for Western blotting and radioimmunolabeling. HMPV N antibodies were obtained
from Abcam, HMPV F 54G10 antibody was a kind gift from Dr. John Williams
(University of Pittsburgh).
FISH probe design
Forty-eight fluorescence in situ hybridization (FISH) probes that target the HMPV
RNA sequence between nt 1 and 5467, which contain the genes for N, P, M, F,
and M2 were synthesized and obtained from Biosearch Technologies. Each probe
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was 20 nt long and linked at the 3’ end to the Quasar 570 fluorophore for probes
complementary to vRNA [120].
PPMO design
Peptide-conjugated phosphorodiamidate Morpholino oligomers (PPMO) were
designed to target and knockdown the HMPV matrix protein. The PPMO was
designed based on the several strains of HMPV, and ultimately, the HMPV strain
CAN97-83 strain used in this study. The 25 nucleotide (nt) PPMO sequence was
designed to encompass 13 nts upstream of the AUG start sequence in the 5’UTR,
and span the first 12 nts of the matrix protein nucleotide sequence.
Phosphorodiamidate Morpholino oligomers (PMO) were obtained from GeneTools. An arginine-rich peptide was added to PMOs to create PPMO by Hong
Moulton and David Stein (Oregon State University). The peptide is a potent aid in
cellular delivery of PPMO [121-123].
Viral propagation
WT HMPV strain CAN97-83, generously provided by of Guy Boivin (Université
Laval, Canada) and recombinant, GFP-expressing HMPV (rgHMPV) strain
CAN97-83 (a kind gift of Peter Collins and Ursula Buchholz, National Institutes of
Health) were propagated in Vero cells. WT HMPV and rgHMPV were propagated
at a starting multiplicity of infection (MOI) of 0.01, and incubated at 32°C with OptiMEM, 200 mM L-glutamine, and 0.3 μg/ml tosylsulfonyl phenylalanyl chloromethyl
ketone (TPCK)-trypsin, which was replenished every day. On days 7-9, cells were
scraped and collected in 1X SPG (218mM Sucrose, 4.9 mM L-glutamic acid, 3.8
mM KH2PO4, 7.2 mM K2HPO4) and frozen at −80°C. The cells were then thawed
at 37 °C and subjected to a total of three freeze/thaw cycles before centrifugation
at 2,500 × g for 20 minutes at 4°C on a Sorval RT7 tabletop centrifuge to clear
cellular debris. The supernatant was then centrifuged on a 20% sucrose cushion
in TNE (50 mM Tris-HCL, pH 7.4, 100mM NaCl, 0.1mM EDTA) for 2 h and 30
minutes at 27,000 × g and 4°C using a SW28 swinging-bucket rotor on a Beckman
Optima L90-K ultracentrifuge. Following centrifugation, the supernatant was
removed, and the pellet was resuspended in 100 uL Opti-MEM per tube and
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incubated at 4°C overnight with rocking to resuspend the viral particles. Samples
were aliquoted, flash frozen and stored at −80°C.
Recombinant GFP-expressing PIV5, a kind gift from Robert Lamb (Howard
Hughes Medical Institute, Northwestern University) and Jessica Robach
(Northwestern University) was grown in MDCK cells. RSV A2 expressing GFP
(rgRSV) was kindly gifted by Medimmune/Astrazeneca. For propagation, an MOI
of 0.1 of rgRSV was added to Hep-2 cells in Opti-MEM. After 3 h incubation, OptiMEM with 2 mM L-glutamine was added and cells were incubated for 4 to 5 days
at 37 ºC. Cells were then scraped and treated with one freeze-thaw cycle. Cell
debris was spun down at 2500rpm and the supernatant made up to 1X of sucrose
phosphate (Hyclone, special order from Astrazeneca/Medimmune). Samples were
aliquoted and flash frozen to be kept at −80°C. Viral titers were determined by
performing serial dilutions and infecting Vero cells in a 96 well plate. The number
of fluorescent cells were counted at 24 h.p.i to determine number of plaque forming
units that were present per mL (pfu/mL).
Time course immunofluorescence assay
Ten mm coverslips were coated with 1 mg/mL of bovine serum albumin, 10 µg/mL
of fibronectin, and 30 µg/mL of collagen in BEBM at 37°C overnight. The following
day, the coating was aspirated, and BEAS-2B cells were seeded on coated
coverslips to be between 65 – 75% confluency by the next day. Infection was
carried out as follows: starting with a multiplicity of infection (MOI) of 4, cells were
inoculated with WT HMPV in Opti-MEM. Cells were immediately incubated at 4°C
for 2.5 hours to synchronize infection. After this, the inoculum was removed and
replaced with fresh Opti-MEM and cells were immediately incubated at 37°C. The
time of media replacement and 37°C incubation denotes 0 hours post-infection
(h.p.i). Following infection, cells were rinsed twice with PBS and fixed in 4% PFA
for 20 minutes at indicated times post-infection. After fixing, cells were washed
three times with PBS and incubated for 15 minutes with permeabilization buffer
(1% Triton-X-100 in PBS) at 4°C. Cells were subsequently washed twice in PBS,
and blocked in 1% NGS for 1 hour. Following blocking, cells were incubated with
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the JOJ anti HMPV M monoclonal antibody at 1:100 in 1% NGS overnight at 4°C.
Cells were then washed seven times with 0.05% Tween 20 in PBS, and incubated
with a TRITC-conjugated secondary antibody at 1:300 in 1% NGS for 1 hour at
4°C. The cells were washed again seven times with 0.05% Tween 20 in PBS,
before being mounted with VECTASHIELD antifade mounting media with DAPI
(Vectorlabs). Images were taken using a Nikon A1 confocal microscope and
analyzed with NIS-Elements software. Images were processed with Adobe
Photoshop with equivalent adjustments made to all channels.
HMPV minigenome luciferase assay
BSR cells expressing T7 polymerase were transfected with pCITE-HMPV N,
pCITE-HMPV P, pCITE-L, pCITE-M2-1, and a minigenome reporter cassette that
encodes a luciferase reporter minigenome construct under control of the T7
promoter using the lipofectamine 3000 system per manufacturers instruction. The
amounts transfected are as follows: minigenome: 1.2 µg; P: 0.12 µg; N 0.12 µg,
M2-1 0.1 µg. For these conditions, an increasing amount of M, up to 2.0 µg was
added to observe effects on minigenome reporter activity. For each condition, the
total amount of DNA transfected was kept constant by making up the difference
with empty pCAGGS. At 24 hrs post-transfection, cells were lysed in a luciferase
lysis buffer and clarified by centrifugation per the manufacturer's instructions
(Promega). For each sample, lysate was loaded into a 96-well plate, where
luciferin was added at a 1:1 ratio of lysate:luciferin. In this case, reporter activity is
read out as the luminescence of enzyme produced with luciferase mRNA is
produced by the minigenome, and the effect of increasing amounts of M on
luciferase activity is measured (Figure 2.4).
Infected cell count after PPMO treatment
Subconfluent Vero cells in 6-well plates were infected with HMPV at an MOI of 4.
The process of infection is described above. At times indicated post-infection, a
final concentration of 5µM of either scrambled (control) PPMO or HMPV M-specific
PPMO diluted in Opti-MEM were added to cells. At 24 hrs post-infection, cells were
lifted with 50mM EDTA for 20 minutes at 37°C. Cells were then transferred to
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FACS tubes, where samples were made up to 2% PFA in solution with EDTA and
PBS. Samples were analyzed using flow cytometry to determine viral titer as a
result of adding PPMO.
Cell toxicity assay
Vero cells were seeded in a 96 well plate. The next day, two-fold serial dilutions of
control or HMPV M-specific PPMO were made in Opti-MEM and added to cells. At
24 hours post-treatment, propidium iodide (Thermo Fisher) was subsequently
added to quantify the ratios of cell death in PPMO-treated samples compared to
untreated samples. Live cells were counted using flow cytometry as a percentage
of the total population (live and dead cells) at the UK flow cytometry core.
Immunofluorescence with fluorescence in situ hybridization (FISH)
Subconfluent A549 and BEAS-2B cells grown on 10mm coverslips were infected
with WT HMPV as described above. At 0 h.p.i., cells were treated with control or
M-specific PPMO as earlier detailed. Cells were then fixed for immunofluorescence
in the protocol detailed above, except FISH was performed before cells were
mounted. After the final washes following incubation with the secondary antibody
for the immunofluorescence portion, cells were once again fixed in 4% PFA for 15
minutes at room temperature. After fixing, cells were washed twice with PBS, and
once with 2x SSC-10% formamide buffer, and then transferred to a humidified
chamber, where they were incubated overnight at 25°C in FISH vRNA probes
diluted at 1:100 in hybridization buffer (4x SSC, 1x Denhardt’s solution, 150 µg/mL
ssDNA, 2mM EDTA, 50% formamide in DEPC treated water). After 24 hours, cells
were washed two times for 20 minutes per wash with 2x SSC-10% formamide
buffer and coverslips were mounted using VECTASHIELD antifade mounting
media with DAPI (Vectorlabs). Images were taken using a Nikon A1 confocal
microscope and analyzed with NIS-Elements software. Images were processed
with Adobe Photoshop with equivalent adjustments made to all channels.
RNA extraction and quantitative real time PCR
A549 cells were grown in 6-well plates overnight until a 75-85% confluency was
reached. Cells were infected using the method described above, and treated with
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PPMO at indicated times post infection. At the indicated times post infection, the cells
were washed twice with PBS and then lysed with 500 μl of TriPure isolation reagent
(Sigma). The total RNA was extracted according to the manufacturer's instructions.
RNA was immediately treated with amplification-grade DNase I (Sigma) for 15 min at
room temperature, followed by inactivation at 70°C for 10 min. Reverse transcription
was performed starting with 500 ng of DNase-treated RNA, 1.25 mM deoxynucleoside
triphosphates, 10 U avian myeloblastosis virus reverse transcriptase (Promega), and
1.25 μM of indicated primers listed in table 2.1. The reaction mixtures were incubated
at 80°C for 10 min and then at 42°C for 60 min. For quantitative PCR, 2 μl of freshly
made cDNA from the reverse transcription described above was mixed with 1.25 μM
each specific primer, Perfecta SYBR green Supermix, and low-carboxy-X-rhodamine
reagent (Quanta Biosciences) according to the manufacturer's instructions. The
assays were performed using a stratagene Mx 3005P system (Agilent Technologies).
The following cycle parameters were used for the experiment: 95°C for 2 min and 40
cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 60 s. The results were normalized
to the average level of expression of the housekeeping gene control, glyceraldehyde3-phosphate dehydrogenase (GAPDH) and tubulin.

Protein expression studies
Detecting viral proteins in HMPV infection in response to PPMO treatment:
Subconfluent A549 cells were infected with rgHMPV or WT HMPV, followed by
PPMO treatment at 0 h.p.i. as described above. 1.5 hours before indicated time
points, cells were rinsed twice with PBS and starved with cysteine-methioninedeficient media for 30 minutes at 37ºC. Following the starve, cells were labeled
with Tran[35S] metabolic label (100 μCi/mL; MP Biomedicals) for 1 hour. Following
the label, the cells were washed three times with PBS and lysed with
radioimmunoprecipitation (RIPA) lysis buffer, and radioimmunoprecipitation was
performed as described in the PIV5 F methods section.
Detecting HMPV M calcium coordinating residue mutants: Subconfluent A549
cells were transfected with pCAGGS-HMPV M using Lipofectamine 3000
according to the manufacturer’s protocol. HMPV M expression (WT and mutants)
was determined by either radioimmunoprecipitation, described above or by
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Western blotting the total lysate. For Western blots, cell lysates were run on 15%
SDS PAGE gels, and transferred to polyvinylidene difluoride (PVDF) membranes
(Fisher) at 50 V for 80 min at 4°C. Membranes were subsequently blocked with
5% milk in Tris buffered saline with 0.05% Tween-20 (TBS-T). Then, membranes
were incubated with anti-AMPV M antibody in 5% milk TBS-T. Membranes were
washed with TBS-T and incubated with anti-rabbit secondary antibody at 1:10,000
(Jackson). Membranes were washed again with TBS-T and visualized with the
LiCor imaging system.
Statistical analyses
The average value and standard deviation from each indicated experiment were
computed. Analyses were generally performed using a two-way ANOVA for
multiple comparisons, or the Student t test for pairwise comparisons. p values are
indicated for each individual experiment. All statistical analyses were performed
using GraphPad Prism software.
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Table 2.1 List of primers used for qPCR experiments.
Target
RT/HMPV vRNA
qPCR/HMPV Pvm/F
qPCR/HMPV Pvm/R
qPCR/hmpv N m/F
qPCR/hmpv N m/R

Primer
AACGCGTATAAATTAAGTTAC
ACCTACCAAACCGACCATATTG
CTTCAGTTTTGATTGCCCCAC
GTGCTGGTCAAACAATGCTG
ACTCAGCTTGGACAGATACATG

qPCR/hmpv M m/F
qPCR/hmpv M m/R
qPCR/hmpv F m/F
qPCR/hmpv F m/R
qPCR/hmpv M2-1 m/F
qPCR/hmpv M2-1 m/R
qPCR/hmpv M2-2 m/F

CTATCAAGGAGAGTGAATCAGCC
GATCAGTCCCGCATAAGGTG
GAGAACATTGAAAACAGCCAGG
AGAGCCAAGGACAGCAATTAG
GCCTGCTACAGTCTACACAAC
AGATGCGGGAGTTTTGCTC
TGACTCTTCATATGCCCTGC

qPCR/hmpv M2-2 m/R
qPCR/hmpv SH m/F

GAGACTTCACTATCCCATCGG
AGACTCACCATCAAATACCACATC

qPCR/hmpv SH m/R
qPCR/hmpv G m/F
qPCR/hmpv G m/R
qPCR/hmpv L m/F
qPCR/hmpv L m/R
Oligo(dT)20

TTATTTTCCAGCATGTGTCCTTG
TCACAGCATCCAACTCAACAG
TGCTGGTTCTGTTTCTGATGG
GCAAGTTCAACCAAGCCTTTAG
GTGTTCCATGTAATTCGTCTGC
TTT TTT TTT TTT TTT TTT TT

Designed by Dr. Cheng-Yu Wu
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Figure 2.1. Workflow of the surface biotinylation protocol.
Cells are transfected with pCAGGS-PIV5 F and incubated overnight. Cells are then
starved, metabolically labeled with radioactive sulfur-containing cysteine and
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methionine. Following the radioactive label, the surface population of cells is also
labeled with biotin before cell lysis and lysate clarification. F proteins are
immunoprecipitated, and at this point 10% is reserved to be analyzed as “total
protein”. The remaining 90% is incubated with streptavidin to distinguish surfaceexpressed F only. The surface protein is boiled to be released from beads, run on
a gel and analyzed by autoradiography.
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Figure 2.2. Schematic representation of luciferase reporter fusion assay.
BSR cells constitutively expressing T7 polymerase were overlaid onto Vero cells
transiently expressing PIV5 F (WT or LIZ), PIV5 HN, and containing plasmids with
luciferase under a T7 promoter. Where PIV5 F is functional, F would merge the
membranes of BSR and Vero cells, giving the T7 polymerase access to the
luciferase in Vero cells under the T7 promoter. Thus, if fusion occurs, luciferase is
synthesized. The readout of fusogenic activity is observed from the reaction of
luciferin in the cell lysates reacting with luciferin. The reaction produces
luminescence, which is quantified by a luminometer.
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Figure 2.3. Principle of thermal triggering assay.
To test the thermostability of the PIV5 F WT or LIZ, cells transfected with either
construct is subject to heat treatment at indicated temperatures for 15 minutes. If
the protein remains in the prefusion conformation, mAb F1a, the prefusion antibody
will still bind, thus secondary antibodies bound can be quantified by flow cytometry.
The lack of mAb F1a binding is a direct function of the amount of F that is triggered
at the surface of cells.
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Figure 2.4. Schematic of the minireplicon system mechanism.
BSR cells constitutively expressing T7 polymerase are transfected with a positive
sense luciferase minigenome under a T7 promoter, along with the viral
components required for viral replication: N, P, L, and M2-1. Once the minigenome
is delivered, T7 polymerase from BSR cells gains access to the +strand
minigenome, and makes a negative sense RNA copy. At the same time, N,P,L,
and M2-1 that are freshly synthesized in the transfected cell can access and read
the -luciferase genome leader and trailer elements, transcribing the minigenome
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into luciferase mRNA. This mRNA is translated into luciferase protein. The -luc
RNA genome is also used as a template for replication: it also directs formation of
+luciferase RNA, which is in turn used to generate more -luciferase template for
mRNA and protein production. Lysates from this when incubated with luciferin
produce varying degrees of luminescence, as a direct readout of the efficiency of
viral elements to support replication and transcription. In this assay, increasing
amounts of M was added to examine its effect on baseline transcription and
replication efficiency of the minigenome system.
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Chapter 3 : PARAINFLUENZA VIRUS 5 FUSION PROTEIN
MAINTAINS PREFUSION STABILITY BUT NOT FUSOGENIC
ACTIVITY FOLLOWING MUTATION OF A TRANSMEMBRANE
LEUCINE/ISOLEUCINE DOMAIN

Portions of this chapter were adapted and reprinted with permission from the
Microbiology Society: Branttie JM, Dutch RE. Parainfluenza virus 5 fusion protein
maintains pre-fusion stability but not fusogenic activity following mutation of a
transmembrane leucine/isoleucine domain. J Gen Virol. 2020 May;101(5):467472. doi: 10.1099/jgv.0.001399. Epub 2020 Feb 25. PMID: 32100701; PMCID:
PMC7414451.
Introduction
Parainfluenza virus 5 (PIV5), measles virus (MeV), and the zoonotic Hendra
virus (HeV) and Nipah virus (NiV), are enveloped viruses that belong to the family
Paramyxoviridae [124]. MeV, HeV, and NiV are highly pathogenic viruses of
worldwide significance [125], while PIV5 serves as an important Paramyxoviridae
viral model system [126]. Although there are vaccines against MeV and its rampant
spread has been mainly checked, there is still a troubling proportion of the global
population that remains unvaccinated [127]. In fact, lack of MeV vaccination is the
leading worldwide cause of preventable deaths in children. For these unvaccinated
groups, MeV causes a range of symptoms, with one of the deadliest being
encephalitis [128]. HeV and NiV similarly can result in encephalitis upon disease
onset, but patients may also have repeated cases of encephalitis following initial
recovery [129]. A combination of HeV and NiV being bat-borne, the high morbidity
and mortality rate, along with the lack of human vaccines or therapeutics [130,
131], make apparent the potential risk of a global henipavirus pandemic. Moreover,
the voluntary lack of vaccinations against MeV potentially poses a threat to herd
immunity, particularly putting immunocompromised individuals at risk. These
observations highlight the need for basic and clinical research in paramyxoviruses
in order to elucidate attractive and novel therapeutic targets.
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Paramyxoviruses contain a non-segmented negative sense (NNS) RNA
genome. Within the paramyxovirus family, virion structures are generally highly
pleomorphic in size and shape [125, 132, 133]. In contrast, cryo-electron
microscopy has demonstrated that PIV5 particles are mostly spherical [133],
similar to Sendai virus (SeV) particles [132]. Paramyxovirus particles range from
between 110 and 540nm in size, with some particles bearing more than one copy
of the viral genome [125, 132]. Data also shows that when compared to other
negative sense RNA viruses such as Influenza and Marburg viruses, the genomic
packaging of SeV appears to be less ordered, in some cases forming a “tangled
knot” [132]. For paramyxoviruses, the RNA copies are encased in nucleoprotein
(N) and are associated with the phosphoprotein (P), which is a polymerase
cofactor, and a large RNA dependent RNA polymerase protein (L) also forming
part of the RNP. Altogether, the viral RNA and its encapsidated proteins form
helical ribonucleocapsid filaments, further protected by a viral glycoprotein-rich
double layered membrane. The two most prominent glycoproteins within the family
are the attachment protein (G/HN/N) and the fusion protein (F), which is largely
responsible for successful entry of viral particles to host cells. The PIV5 attachment
protein is denoted by HN for its hemagglutinin neuraminidase activity [134].
For these enveloped viruses, successful infection requires fusion of their
membranes with target cell membranes to allow for content mixing [41, 53]. Since
membrane fusion is energetically costly [135] , F and G/HN/H serve as critical viral
surface proteins that lower the kinetic barrier to drive the fusion and entry process.
The fusion proteins of PIV5 and other paramyxoviruses are folded into
homotrimers within the endoplasmic reticulum (ER) as they are synthesized.
These proteins contain a fusion peptide (FP), heptad repeats A and B, the
transmembrane domain (TMD) and a cytoplasmic tail. For fusion to occur, the
attachment protein tethers the viral particle to the host cell via interactions with
cellular receptors; subsequently, the F protein drives the fusion process by
undergoing large-scale, essentially irreversible conformational changes from a
metastable pre-fusion structure to a highly stable post-fusion conformation that
results in the merging of the viral and target cell membranes [44, 45, 134]. These
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conformational changes entail the unraveling of the HRA and FP from the
ectodomain head and movement of these regions towards the target cell, where
the FP is initially inserted to form a pre-hairpin intermediate. As this state is less
energetically favorable, the protein then refolds into a low energy conformation,
creating a six-helix bundle of the HRA and HRB domains, and merging the two
membranes to create a fusion pore [53]. This fusion pore must expand before viral
RNA can pass into the host cell, with expansion postulated to be mediated in part
by the cytoplasmic tail (CT) of the paramyxovirus fusion protein [136].
Like other class I fusion proteins, paramyxovirus F proteins are synthesized
in a metastable prefusion state and folded in ER into the homotrimer that must be
proteolytically cleaved to become fusogenically active [135]. The cleavage event
unveils a FP that interacts with the target membrane to facilitate the
aforementioned fusion process [137, 138]. Upon synthesis, the HeV F is trafficked
through the secretory pathway to be expressed on the cell surface in its
fusogenically inactive form (F0). Subsequently, HeV F0 is endocytosed and cleaved
by the protease cathepsin L within endosomes and retrafficked to the surface in a
disulfide-linked fusogenically active form (F1 +F2) [41, 139]. Conversely, PIV5 F
trafficking is more straightforward: it is similarly synthesized in the secretory
pathway, but undergoes cleavage within the trans-Golgi network (TGN) by furin
during transport to the cell surface to be expressed as F1 + F2 [41, 44, 134, 139,
140]. Importantly, throughout the trafficking process, paramyxovirus F proteins
must be maintained in a metastable pre-fusion state, as premature triggering
renders the protein fusion inactive [74].
Although certain paramyxovirus F proteins such as SeV F can trigger in the
absence of their homotypic attachment proteins [141], most paramyxoviruses
engage in complex interactions with their attachment proteins to begin refolding
from the pre-fusion to the post-fusion state [134, 142]. Indeed, the triggering of
fusion by initiation of conformational changes still presents as a significant gap in
our knowledge fusion regulation. A number of studies have focused on how
external domains and cytoplasmic tails of F proteins impact fusion. Many of these
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focus on possible interactions with the attachment protein in transmitting
conformational changes after attachment to signal the F protein to trigger. [53, 143,
144]. Interestingly, an unsuspected player, the transmembrane domain (TMD),
which was initially thought to mainly serve as a membrane anchor, has recently
been shown to play critical roles in the pre-fusion stability of the paramyxovirus F
proteins [41, 74, 145-149]. In isolation, the TMDs of HeV F, PIV5 F and the closely
related pneumovirus human metapneumovirus (HMPV) F self-associate in trimers.
For HeV F, an AXXXG motif, similar to the GXXXG motif known to support
association of hydrophobic residues, was found to be important for maintaining
surface levels of the cleaved prefusion form [41]. On further investigation, another
important association motif, the leucine/isoleucine (L/I) zipper was identified in the
TMD of HeV F and similar β-branched residues in heptad repeats were found for
140 other paramyxoviruses, including PIV5 F. Studies on HeV F showed that not
only is the L/I zipper important for the self-association of the TMDs in isolation, but
it is also important in the pre-fusion stability of the full HeV F protein, and
circumvents premature triggering and misfolding. These studies showed a severe
reduction in surface and total expression for the HeV L/I zipper mutants, termed
LIZ mutants. Not surprisingly, HeV F LIZ mutants are also deficient in forming
syncytia, a consequence of not being stably present on the cell surface ([74, 145,
146].
This exciting finding of a potential TMD target that could abrogate viral infection
led our group to probe the extent to which the L/I zipper drives fusogenic activity
in other closely related viruses. To examine this, we used PIV5, a model
paramyxovirus. We introduced alanine mutations to the L/I zipper of PIV5 F to
create a PIV5 F LIZ mutant. Our data show that the PIV5 LIZ mutant is expressed
on the surface and total levels in similar ways to WT. Surprisingly, despite the
relative abundance of potentially fusogenically active pre-fusion PIV5 F LIZ on the
surface of transfected cells, there is a considerable decrease in the functionality of
the fusion protein, suggesting that the L/I zipper is a potentially relevant target in
preventing entry of paramyxoviruses.
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Results
HeV F LIZ and PIV5 F LIZ localize differently from WT
Understanding the roles of the transmembrane domain in facilitating
functional activities of the fusion protein requires extensive study of its oligomeric
associations. Recently, SAXS and solid state NMR data have corroborated studies
from the Dutch lab that PIV5 F TMD associates in a trimer [41, 74, 145, 148]. Our
lab has shown that for HeV F, these trimeric associations are at least in part
supported by the hydrophobic interactions mediated by the heptad repeat L/I
zipper [74]. Given these observations, we were interested in whether LIZ mutations
affected the placement of the fusion protein of HeV in transfected cells. Surface
expression of the fusion protein is important in orienting it for proper assembly into
viral particles and for positioning for syncytia formation. Additionally, we were
interested in the role of the TM L/I zipper motif in paramyxovirus F proteins to
examine whether the L/I zipper functionality observed in HeV F is conserved
across the family. To address these questions, we introduced TM L/I zipper alanine
mutations to create PIV5 F LIZ (Figure 3.1). With this mutant, we performed
immunofluorescence on cells to analyze the intracellular localization compared to
PIV5 F WT. Our results demonstrate that while HeV F WT displays a ubiquitous
cellular distribution, HeV F LIZ is mostly confined in pockets around the nucleus
consistent with the placement endoplasmic reticulum (Figure 3.2 A). These
observations corroborate previous data that showed that surface and total
expression of HeV F LIZ was considerably lower than for HeV F WT [74].
Interestingly, we found that PIV5 F WT primarily localizes at the surface of
the cell and is present within membrane ruffles, while PIV5 F LIZ shows a higher
level of intracellular distribution. We further examined multiple focal planes of cells
transfected with PIV5 F WT and LIZ using Z-stacks (Figure 3.2 B). We found that
PIV5 F WT is mostly absent from the immediate perinuclear region in different
optical slices, but PIV5 F LIZ is distributed more evenly throughout the cells and is
present in puncta close to the nucleus. These results suggest a more subtle yet
significant effect of the PIV5 F L/I zipper in trafficking and intracellular localization
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of the protein. Likewise, these data indicate a more modest effect of the TM L/I
zipper in protein folding for PIV5 F than for HeV F.
PIV5 F LIZ is expressed comparably to PIV5 F WT in time course
Our data showed that not only was HeV F trafficking impaired, but levels of
expression were dramatically affected by the L/I zipper [74]. Sustained expression
and stability of the fusion protein is paramount to its biological activity and could
affect the ability of the full viral particle to be infectious over longer periods of time.
We were interested in whether the role of the L/I zipper in stable HeV F expression
is preserved across the paramyxovirus family. If paramyxovirus fusion proteins
need TMD L/I zipper interactions to be stably maintained in their pre-fusion form
during infection, their removal would reduce the lifespan of the fusion protein.
Therefore, to biochemically assess the effect of the L/I zipper on PIV5 F synthesis
and stability, we performed a pulse-chase time course assay, using PIV5
cytoplasmic tail antibody 516–529, to examine PIV5 F WT and PIV5 F LIZ stability
(Fig. 3.3). Previous studies showed that total expression over time for HeV F LIZ
was significantly decreased compared to WT [74]. Surprisingly, between 0 and 8 h,
PIV5 F LIZ expression was comparable to WT, suggesting that the PIV5 F L/I
zipper is not critical for stability, unlike the L/I zipper of HeV F [74]. This observation
indicates that the L/I zipper is not critical for all paramyxovirus fusion protein
stability.
Surface expression of pre- and post-fusion PIV5 F is moderately affected
by the L/I zipper
Since the presence of F at the membrane is crucial for biological activity,
we probed the surface expression of PIV5 F WT and LIZ in transfected cells using
a surface biotinylation assay. We found that after radiolabeling newly synthesized
F protein for 3 h with S35 at 18–24 h post-transfection, PIV5 F LIZ surface
expression is decreased by more than 30 % when compared to WT. In contrast,
total amounts of protein between PIV5 F WT and LIZ remain comparable (Figure
3.3 A and B). The antibody, anti PIV5 F 516–529, that was used in this experiment
is able to detect both pre-and post-fusion forms of the protein, indicating that the
sum of pre-fusion and post-fusion forms of PIV5 F WT is slightly higher at the cell
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surface than for PIV5 F LIZ. From these findings, we conclude that L/I zipper
interactions do not significantly affect the overall sum of protein expressed;
however, taken with Figure 3.2, the data show that the PIV LIZ mutant shows some
redistribution throughout the cell compared to the PIV5 F WT. Surprisingly, PIV5 F
LIZ mutations displayed a slightly higher cleavage ratio for surface expressed F
than for WT. This may be a result of increased intracellular localization because of
the LIZ mutations, as longer retention of PIV5 F LIZ within the TGN would provide
extended exposure to the cleavage protease furin before the F protein is finally
transported to the cell surface.
The L/I zipper mutations ablate fusogenic activity of the fusion protein
While data shown in Figure 3.4 show that PIV5 F WT and LIZ are expressed
at comparable levels at the cell surface, we were interested in selectively
quantifying the population of potentially fusogenically active protein at the surface.
We performed flow cytometry with the pre-fusion-specific PIV5 F mAb F1a. These
data also show that the pre-fusion form of PIV5 F LIZ is only slightly lower than for
PIV5 F WT (Figure 3.5). This suggests that although there is a slight decrease in
metastable, pre-triggered PIV5 LIZ F on the surface of cells, there is still a
significant presence of potentially fusogenically active PIV5 at the surface of cells
in the absence of the L/I zipper.
Having established that pre-fusion PIV5 F LIZ can still be trafficked to the
surface of cells, we utilized a syncytia assay to test the fusogenic activity of PIV5
F LIZ in comparison to WT. When expressed with its homotypic attachment
protein, PIV5 F can form syncytia in vitro. We used this model to examine
functionality of the PIV5 F LIZ mutant in comparison to WT. We observed that PIV5
F WT is highly fusogenic, as the expression of PIV5 F WT with HN resulted in BHK
cells fusing into a few, very large syncytia. Remarkably, syncytial activity was
abolished in the PIV5 F LIZ mutant (Figure 3.6 A). Further characterization of
fusogenic activity using a luciferase reporter system also showed quantitatively
that the PIV5 F TM L/I zipper is critical for fusion (Figure 3.6 B). Notably, a leucine
residue at position 468 (L486) has been reported to be important for fusogenic
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activity. L486 was shown to be critical for both membrane mixing and content
mixing, thus identifying L486 as essential in the events leading up to the merge of
lipid bilayers driven by F [147]. L486 is present in the proposed L/I zipper of PIV5
F, corroborating this finding in the context of the L/I zipper.
PIV5 F LIZ mutants are triggered more readily at 55 and 60 ºC
The comparable PIV5 F WT and LIZ pre-fusion surface expression levels,
in contrast to the dramatic decrease in HeV F LIZ versus HeV F WT, show that L/I
zippers in the TMDs of HeV F and PIV5 F play distinct but critical roles in
maintaining biological activity. While these studies suggest that fusion, rather than
surface or total expression, is significantly affected by residues within the PIV5 F
TM L/I zipper, the exact mechanism by which these LIZ mutations abrogate fusion
is currently unknown. To understand whether PIV5 F LIZ is capable of being
triggered from its pre-fusion form to undergo the conformational changes that are
critical for membrane fusion, we transfected cells with either PIV5 F WT or PIV5 F
LIZ for a thermal triggering assay.
Previous studies show that PIV5 F can be triggered in the absence of its
cognate attachment protein when exposed to heat [144, 150]. Thus, PIV5 F WTand LIZ-expressing cells were exposed to increasing temperatures (Figure 3.7),
and flow cytometry using the pre-fusion-specific mAb PIV5 F1a was utilized to
quantitate the levels of pre-fusion F. Triggering of conformational changes in
response to heat would lead to loss of F1a binding. Our results show that as the
temperature increased, the detected levels of pre-fusion F decreased for both the
WT and LIZ F proteins. Interestingly, at 55 and 60°C, a statistically significant
increase in the triggering of PIV5 F LIZ compared to WT was observed, potentially
indicating a role for the TM L/I zipper in stabilizing PIV5 F in the pre-fusion
conformation. This stabilization is less dramatic than was observed for HeV F [74],
but does suggest that a role for the LIZ in pre-fusion stability may be a property
across the viral family. However, it is unlikely that this small decline in the
thermostability of pre-fusion PIV5 F LIZ would fully account for the drastic loss of
fusogenic activity shown in the syncytia and reporter gene assays.
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Discussion
A number of studies map out the conformational changes that
paramyxovirus fusion proteins undergo once triggered [41, 45, 53, 136, 140, 144,
147, 150-152]. However, there is still a gap in our knowledge of what supports the
maintenance of the pre-fusion conformation in a metastable, less energetically
favorable conformation than the post-fusion structure until the appropriate window
for fusion opens. Our studies sought to understand the relevance of a TMD L/I
zipper, an association motif found to be important in stability, expression, and
functionality of HeV F [41, 74, 145], in stabilizing the fusion protein for proper
function across the paramyxovirus family. We performed mutagenesis of the L/I
zipper of PIV5 F and probed whether the TMD L/I zipper potentially affected
stability of this second paramyxovirus protein. Our examination into L/I zipper
potentially affecting protein stability involved two questions:
1. Does the L/I zipper affect fusion protein turnover for PIV5 F?; and
2. Do mutations in the L/I zipper confer changes to readiness of F to be triggered?
Our results demonstrate that there is no significant difference in the protein
turnover of the PIV5 F protein once LIZ mutations were made (Figure 3.2). These
results are in direct contrast to our previous observation of HeV F [74], highlighting
a difference in the mechanism of potential function of the L/I zipper within the
paramyxovirus family. However, our data interestingly showed that for both HeV F
and PIV5 F, the L/I zipper contribute to F surface expression, albeit to varying
degrees (Figure 3.2; Figure 3.4; Figure 3.5). Previous studies in our lab have
implicated the TMDs of paramyxovirses in appropriate trafficking of the fusion
protein [66, 67]. Although data from HeV F largely suggest that improper trafficking
results from a higher tendency of the fusion protein to dissociate or misfold [74],
this current study shows that total amounts of PIV5 F are maintained, and only the
proportion of protein that is expressed on the surface is reduced for LIZ mutants.
It is tempting to suggest then, that based on this data and on cumulative data from
TMD trafficking studies across the paramyxovirus family, the TMD L/I zipper plays
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a role in trafficking of the virus to the cell surface. From this study, another
important parallel in the role of paramyxovirus TMD L/I zippers is drawn: the TMD
L/I zipper is critical for functionality of the fusion protein for both HeV F and PIV5
F. In our studies, although there is ample pre-fusion F present at the cell surface
with the PIV5 F TMD L/I zipper was mutated to alanine, we found that fusion activity
was ablated (Figure 3.6).
Reports show that for class I fusion proteins such as Ebola virus GP2,
influenza virus HA and PIV5 F, the FP and TMDs interact in the post-fusion
conformation [138, 148, 153, 154]. It is possible that for PIV5 F, the L/I zipper within
the TMDs contributes to making essential contacts with the fusion peptide to hold
the post-fusion conformation in place and merge viral and target membranes.
Additionally, studies demonstrate that the TMs of class I fusion proteins induce
local membrane changes that decrease the energy barrier needed for fusion [137,
148, 155] – as such, the L/I zipper of PIV5 F may contribute in this local disruption.
Finally, it is important to note that PIV5 F is known to make contact with HN through
an Ig-like domain at the ectodomain [144]. The L/I zipper may be involved in
transmitting conformational changes that result from this initial contact, and thus in
refolding. Alternatively, F could have important interactions with HN through
contacts with the TMD L/I zipper, which are disrupted by the LIZ mutations.
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Figure 3.1. Mutations to the L/I zipper of HeV F and PIV5 F.
Schematic of the paramyxovirus fusion protein highlighting the TMD L/I zipper of
HeV F and PIV5 F, and the mutant constructs. FP, fusion peptide; HRA, heptad
repeat A; HRB, heptad repeat B; TMD, transmembrane domain; CT, cytoplasmic
tail); S–S, disulfide bond.
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Figure 3.2. Immunofluorescence to visualize localization of HeV and PIV5 F
proteins.
Vero cells were seeded in eight-well chamber plates and transfected with PIV5 F
WT or LIZ mutant (left), and HeV F WT or LIZ mutant (right). Localization of HeV
F was analyzed with anti-F 5G7 antibodies, and PIV5 F analysed with mAb F1a
(green) (A). Images were taken with a Nikon 1A confocal microscope. Images are
representative. Scale bars represent 10 µm. (B). Z-stack images from (A) were
collected in 0.3 µm sections, and images corresponding to top, bottom and middle
slices are shown. Images are representative of two independent experiments
carried out in triplicate. Scale bars represent 10 µm.
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Figure 3.3. Expression and stability of PIV5 F WT and LIZ are comparable.
A. A pulse-chase experiment was carried out 18 h after cells were transfected with
2.5 µg of indicated DNA for Vero cells in six-well plates. Following a 30-minute S35
metabolic radiolabel, samples were chased for indicated times. (B). Quantitation
of PIV5 F and LIZ expression shown in (A). Expression levels of total F protein
(F0+F1) were determined by band densitometry normalized to WT levels. The
averages represent three independent experiments, each carried out in duplicate.
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Figure 3.4. Surface and total expression of PIV5 F protein.
(A) Surface (left) and total (right) expression levels of PIV5 F WT versus PIV5 F
LIZ. (B) Quantitation of expression levels (left) and percentage cleavage (right) of
surface and total PIV5 F protein. The averages represent three independent
experiments, each carried out in duplicate. The LIZ mutant was compared to WT
using Student’s t-test. *, P<0.05; **, P<0.005
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Figure 3.5. Flow cytometry to quantify expression of prefusion PIV5 F only
present at the surface of cells.
Flow cytometry was performed on Vero cells transfected with WT or LIZ PIV5 F.
The averages represent three independent experiments, each carried out in
duplicate. The LIZ mutant was compared to WT using Student’s t-test. *, P<0.05;
**, P<0.005; ****P<0.0001
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Figure 3.6. Mutations to the L/I zipper of PIV5 reduce F-mediated fusion
activity.
(Left). Syncytia assay. BHK cells plated in six-well plates were transfected with
2.5 µg of total DNA with the PIV5 HN attachment protein alone, PIV5 WT F and
HN or PIV5 LIZ F and HN. Syncytia formation was analyzed 24 h post-transfection.
Images were taken with a Nikon TS100 microscope. White arrows indicate
syncytia. Images are representative of two independent experiments, each carried
out in triplicate. (Right). Luciferase reporter gene assay to quantify F fusogenic
activity. Vero cells in 24-well plates were transfected with 1.0 µg total DNA with a
T7 promoter plasmid and PIV5 F WT+HN or pIV5 F LIZ+HN. The following day,
Vero cells were overlaid with BSR cells and incubated for 3 h to allow for luciferase
production. Luciferase activity was measured using a luciferase assay system. The
average represents three independent experiments, each performed in duplicate.
Comparisons were performed using student’s t-test, ****P<0.0001
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Figure 3.7. Thermal triggering assay to observe PIV5 F WT and LIZ
prefusion thermostability.
Cells expressing surface PIV5 F or WT were exposed to 4, 37, 55, 60 or 65 °C for
15 min. Cells were immediately placed on ice for 15 min and prepared for flow
cytometry using PIV5 mAb F1a. The average represents two independent
experiments, each performed in triplicate. The LIZ mutant was compared to WT
using a using Student’s t-test. ****P<0.0001
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Chapter 4 : ROLES OF HUMAN METAPNEUMOVIRUS MATRIX
PROTEIN BEYOND ASSEMBLY
This work was performed in collaboration with Dr. David Stein and Dr. Hong
Moulton (Oregon State University), who we consulted with for the design of PPMO.
Drs Stein and Moulton also synthesized the arginine-rich peptide conjugated to the
PPMO used in figure 4.5 – 4.9. In addition, Dr. Gaya Amarasinghe (Washington
University in St. Louis) produced the IP/MS data shown in Table 1, and Dr. ChengYu Wu (University of Kentucky) performed all qRT PCR experiments (Figure 4.8),
as well as immunofluorescence in Figure 4.9 A and C.

Introduction
Human metapneumovirus (HMPV) is an enveloped virus that was
reclassified in 2016 from the Paramyxovirdae family into the Pneumoviridae family
[156]. It was discovered in 2001, although it is known to have been in circulation
for several decades before its isolation—at least since 1958 [157]. Most people
contract HMPV by the age of five, and reinfections are common throughout life
[157, 158]. Clinically, HMPV manifests as flu-like symptoms in patients; however,
for preterm infants, immunocompromised individuals and the elderly, HMPV inflicts
more severe symptoms including asthma exacerbation, bronchiolitis and
pneumonia, putting this category of patients at higher risk of mortality [157,
159-162].

For

HMPV,

there

is

currently

no

available

FDA-approved

therapeutic or vaccine, and much of its treatment involves supportive therapy
[163]. It is therefore important to elucidate novel and effective therapeutic targets
by understanding the molecular basis of HMPV infection.
The pneumovirus family contains two important human pathogens: HMPV
and respiratory syncytial virus (RSV) [156]. The closely related viruses are highly
heterogeneous in shape and size, with some particles bearing filamentous or
asymmetric morphology, and others being spherical [157, 164-166]. HMPV viral
particles feature host-derived membranes that are studded with multiple copies of
the following surface glycoproteins: the attachment protein (G), which although is
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necessary for attachment and entry for the closely related Paramyxoviridae, is
dispensable in pneumoviral infection [57, 167]; the fusion protein (F), which
undergoes large scale conformational changes to merge the viral and target
membrane [168, 169]; and the small hydrophobic protein (SH), which is a proposed
viroporin [169].
Upon entry and release of the HMPV viral genome into the host cell,
discrete cytosolic pockets termed inclusion bodies (IBs) are formed [120]. HMPV
IBs are membrane-less structures, and by analogy to similar viruses are thought
to be formed through liquid-liquid phase separation (LLPS) [77, 80, 170, 171]. IBs
are commonly formed among NNS RNA viruses and in most cases function as
primary sites of efficient viral replication and transcription [76, 77, 120, 172-178].
Within IBs, there is a viral RNA-dependent RNA polymerase complex, which
consists of the large protein (L) and the polymerase cofactor, phosphoprotein (P).
The polymerase complex uses viral genomic (v)RNA encapsidated nucleoprotein
(N) as a template for replication and transcription. The matrix 2-1 (M2-1) protein
can also be associated with the polymerase and facilitates processivity, allowing
for efficient transcription and translation in the IBs [179, 180].
Pneumo- and paramyxovirus vRNA is encapsidated by the nucleoprotein
(N) and flanked by a leader (le) sequence at the 3’ end, and a trailer (tr) region at
the 5’ end, with both le and tr being variable in length [32, 181]. In addition,
individual genes are flanked by shorter (10-13 nt long) gene start (gs) and gene
end (ge) sequences. For transcription to occur, the viral polymerase first
associates with the le promoter sequence and scans the vRNA template for the
first gs sequence. At the gs, the polymerase initiates transcription, with the gs
playing a role in directing the capping of the RNA transcript. Transcription
continues until the polymerase encounters the ge, where it creates a poly(A) tail
and releases the nascent viral mRNA. The polymerase subsequently moves on to
the next ge signal and transcribes each gene independently through this
mechanism [32, 181-183]. The mRNA products are thought to be trafficked out of
IBs into the cytosol, where they are translated into viral proteins [120, 184]. This
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same encapsidated vRNA that is carried by the virus into cells is used to generate
antisense genome RNA (+RNA), which is further used to generate nascent copies
of vRNA. In this case, the polymerase interacts with the vRNA le region to start
antigenome synthesis but ignores ge and gs signals to create a full antisense RNA,
that in turn serves as a template for more vRNA production [32, 120, 182]. A recent
report from our group showed that HMPV transcription and replication rates are
increased between 6 hours post infection (h.p.i.) to 12 h.p.i. In fact, HMPV IBs
coalesce in an actin-dependent manner during infection to boost the efficiency of
replication and transcription [120].
Although the presence of the N and P proteins are the basic requirements
for pneumovirus IB formation [174, 185], the matrix (M) proteins of RSV and the
paramyxovirus NiV have been documented to be associated with inclusions [76,
95, 108]. NiV M was shown to colocalize with inclusion body species that are
present at the plasma membrane later in infection [76], corroborating a
longstanding observation that NNS RNA virus M proteins serve as adaptors
between viral ribonucleoproteins (RNP)s and the plasma membrane [44, 166, 186,
187]. Indeed, for many non-segmented negative sense (NNS) RNA viruses, the
matrix protein is thought to be a master regulator of viral infection. Viral matrix
proteins are typically peripheral membrane proteins and for Newcastle disease
virus (NDV), HMPV, RSV, and Ebola virus (EBOV), interact with the plasma
membrane through electrostatic interactions: positively charged surfaces on the
matrix proteins associate with the negatively charged inner leaflet of the plasma
membrane [83, 188-190]. Underneath the plasma membrane, like I-BAR domaincontaining proteins [191], M proteins polymerize to form a grid-like array and
induce membrane curvature and allow for budding of nascent viral particles [44,
83, 186, 187, 189, 190, 192]. For some viruses such as EBOV, VP40 alone can
form authentic virus-like particles [190]. In addition to RNPs, M is known to
associate with the cytoplasmic tails of surface glycoproteins, thus M is not only
important for budding but also for assembly of viral particles, particularly at late
stages during infection [44, 108, 193].
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Despite M having been well-established as a key player in late-stage
infection, some of the function of M has proven to be enigmatic. Recent studies
have shown that M may play roles in early infection: several NNS RNA matrix
proteins traffic to the nucleus in early infection although NNS RNA viruses are
mostly known to only involve cytosolic steps in their life cycle [95, 194-196]. Upon
trafficking to the nucleus shortly after being synthesized, NiV M is ubiquitinated.
This ubiquitination is not only important for nuclear exit, but also allows the matrix
protein to associate with the plasma membrane upon nuclear export and facilitates
its performance in assembly and budding [161]. Another unexpected feature of a
pneumovirus matrix protein, HMPV M [83], is that to date, it is the only NNS RNA
viral matrix protein that was co-crystalized with calcium. Although calcium is a
potent signaling modulator [197], it is unclear what roles calcium binding confer to
HMPV M.
In this study, we show that HMPV M is trafficked to the nucleus, and the
timing of nuclear transit coincides with the previously examined height of HMPV
replication and transcription [120]. Though extensive work has elucidated the
mechanisms of nuclear entry and exit for some NNSV M proteins [194, 198, 199],
there is a gap in our knowledge on the purpose of nuclear transit for the majority
of these cases. Thus, our studies sought to bridge the gap by knocking down the
matrix protein early in infection to address effects on early infection. We utilized
antisense phosphorodiamidate Morpholino oligomers to selectively knock down
HMPV M during infection to dissect the role of M during the course of infection.
Preliminary data show that HMPV M is critical for establishing viral replication and
transcription. Additionally, we address the role of calcium binding in HMPV M by
examining expression and conformation of HMPV M with mutations in the calciumcoordinating residues. We find that in addition to the previously published role of
calcium in thermostability of the protein [83], calcium is important in proper folding
of the matrix protein.
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Results
HMPV M travels in and out of the nucleus during the course of infection.
The bulk of the NNS RNA viral life cycle occurs within the cytosol. Outside
of the Bornaviridae family, Mononegavirales do not require nuclear events for
transcription, replication, and assembly. One of the key modulators of infection is
the matrix protein, which interacts with viral and cellular proteins to play essential
roles in late infection to assemble and bud virions from the host cell. Interestingly,
several matrix proteins of NNS RNA viruses have been shown to associate with
the nucleus and with nuclear factors [95, 194, 195, 198]. Table 4.1 shows an
interactome generated from immunoprecipitation (IP) of HMPV M from transfected
cells, followed mass spectrometry (MS) of host-associated proteins. Along with
HMPV M transfection, cells were treated with polyinosinic:polycytidylic acid, poly
(I:C), a synthetic double stranded RNA that potently mimics viral infection and
induces Toll-like receptor 3 (TLR 3), MDA5, and RIG-I response [200, 201]. Among
the list of interacting proteins with HMPV M is the GTP binding nucleoprotein Ran,
a nuclear import factor [202] (Table 4.1). This IP/MS data supports an interaction
of HMPV M with some nuclear factors, potentially consistent with HMPV M traverse
to the nucleus. To follow up on the possibility of M being trafficked into the nucleus,
we infected cells with wild type (WT) HMPV, at a multiplicity of infection (MOI) of
4, and fixed cells at indicated times for immunofluorescence (IF) analysis. Our data
show that by 6 hours, there is evidence of matrix protein synthesis in punctate
structures within the cell. By 10 hours post infection (h.p.i.), M is primarily present
in the nucleus (Figure 4.1). As infection progresses from 12 h.p.i. through 30 h.p.i.,
the presence of M in infected cells shifts to favor a cytosolic distribution, with most
of M associated in filamentous structures as infection progresses past 18 hours
(Figure 4.1 D – F; I – L).
HMPV M moderately affects minigenome replication
Some NNS RNA virus matrix proteins are documented to affect viral
replication and transcription. For example, in a minigenome assay, both EBOV
matrix proteins (VP24 and VP40) were discovered to inhibit viral replication [109].
Previous work has shown that the highest rates of HMPV replication occur
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between 6 – 12 h.p.i. [120], consistent with the hypothesis that nuclear localization
of M may prevent replication inhibition, and in line with the timing of nuclear
accumulation of M shown in Figure 4.1. From these observations, we hypothesized
that HMPV M has a negative effect on viral replication and transcription, and is
therefore sequestered away from the cytosol into the nucleus to allow viral
replication to efficiently occur. To test this hypothesis, we employed a minigenome
luciferase reporter gene system, kindly provided by Dr. Rachel Fearns, Boston
University. BSR cells were transfected with the components required for efficient
viral replication (HMPV N, P, L, and M2-1) in addition to a reporter gene plasmid
containing a luciferase reporter cassette. We assessed the efficiency of reporter
gene translation as a readout for the efficiency of viral transcription and replication
in the context of increasing amounts of M. Our data show that at adding M to the
reporter gene assay moderately affects reporter gene activity. It is noteworthy that
upon addition of 2.0 µg of HMPV M to the minigenome system, we notice an
inconsistency in the general trend of decreased minigenome activity in response
to increasing amounts of M. It is possible that this data point is an experimental
outlier. Further experimental repititions are necessary to determine if the change
at this concentration of M is significant (Figure 4.2).
Given the moderate effect of M on the minigenome system, we were
interested in examining the role of M the context of infection. To examine the
hypothesis that HMPV M has effects on replication and transcription during the
course of infection, we designed antisense peptide-linked phosphorodiamidate
Morpholino oligomers (PPMOs) to knock down HMPV M protein levels (Figure 4.3
A). PMOs are nucleoside analogs that sterically inhibit protein synthesis [203].
Linking an arginine-rich sequence to the 5’ end of the PMO sequence allows for
non-toxic, efficient delivery across cellular membranes [121]. PPMOs can be
engineered to target the 5’untranslated region (UTR) and AUG start codon, thereby
preventing the assembly of the small and large ribosomal subunits [123, 203]
(Figure 4.3 C and D). Recently, PPMOs have shown to be potent, easy-to-use
inhibitors of specific viral protein translation during infection [122, 170, 204].
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To design a PPMO to specifically target HMPV M, we examined the 5’UTR
of 44 disparate strains of HMPV (Figure 4.3; appendix i). We designed an
antisense PPMO based on the conserved 13 nucleotide sequence of the 5’UTR
combined with the first 12 nucleotides of the matrix protein nucleotide sequence,
using CAN97-83 as our reference sequence, since it is the strain used in this study.
This yielded a 25 nucleotide-long antisense PPMO for HMPV M knockdown.
PPMO are incredibly specific, requiring only a five nucleotide mispairs for ablation
of function [123, 205]. Our analysis shows that compared with 5’UTR regions of
other viral proteins, there is not enough sequence identity for M PPMOs to have
off-target effects (Figure 4.4) In addition to the M-specific PPMO, we designed a
negative control scrambled PPMO, which is a nonsense PPMO with no known
cellular or viral target.
PPMO cell toxicity and knockdown of M
To address the role of M early in infection, we initially examined the effect
of the PPMO on cell viability with different concentrations of PPMO, up to ten times
the required amount for inhibition, in 2-fold serial dilutions. Our results demonstrate
that even at the highest amounts, there is no significant effect of the PPMO on cell
viability (Figure 4.5). We next tested the efficiency of the PPMO to knockdown
HMPV M during infection with a recombinant GFP-expressing (rg) HMPV. We
found that without treatment, by 24 h.p.i, M had increased by approximately 5-fold
compared to samples taken from our 6 h.p.i time point. However, when PPMO
were added at 0 h.p.i, expression between 6 h.p.i and 24 h.p.i was maintained at
similar levels, indicating that the PPMO was able to prevent significant translation
of HMPV M (Figure 4.6 A and C).
We also addressed the effect of the M-specific PPMO on another viral
protein, F. We found that surprisingly, despite lack of significant sequence
similarity with the PPMO target, F synthesis was also dramatically reduced (Figure
4.6 B and D). These data suggest that knocking down M potentially affected the
transcription of other viral proteins.
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PPMO reduce rgHMPV titer, but not rgPIV5 or rgRSV
Based on our surprising result with HMPV F, we were interested in whether
the PPMO potentially affected the establishment of infection in cells. We infected
cells with rgHMPV at an MOI of 4, and then treated cells at 0, 4, and 6 h.p.i., with
either the scrambled PPMO or the M-specific PPMO. At 24 h.p.i., we fixed and
visualized cells, and also performed flow cytometry to quantify the number of cells
that expressed GFP as a readout of the number of infected cells. Our results show
that after addition of the M-PPMO at the indicated times post infection with analysis
at 24 h.p.i., the number of infected cells is reduced, suggesting that M plays roles
during early infection (Figure 4.7 A and D). Additionally, we wanted to address
whether the effect the PPMO was specific to HMPV, so we performed the same
analysis on two related viruses: RSV and the paramyxovirus, PIV5. There was no
significant effect of the HMPV M-targeting PPMO on the number of infected cells
present when in the case of either rgPIV5 or rgRSV, suggesting that M PPMO were
specific to reducing HMPV infection (Figure 4.7 B, C, E, F).
PPMO knockdown of M shows a dramatic reduction of viral genomic and
mRNA but shows no effect on cellular mRNA
Having established that the number of cells infected is reduced specifically
for HMPV following PPMO treatment, we analyzed the effect of the PPMO on viral
mRNA, and compared it to cellular mRNA following infection. Cells infected with
HMPV at a MOI of 4 were treated with the scramble or M-specific PPMO at 0 h.p.i.
At indicated times post infection, M-PPMO-treated and control cells were
harvested, with RNA extracted for quantitative real time polymerase chain reaction
(qRT-PCR) analysis. Our data show that for all time points, M-PPMO treatment
resulted in a dramatic decrease for all viral mRNA (Figure 4.8 A-C). At 6 and 8
h.p.i., specifically, the decrease in viral mRNA occurred according to the gene
order: PPMO treatment rendered N most affected, followed by P, M, F, M2-1, M22, SH, and G, with L being the least affected in the above order. As infection
progressed, we observed by 12 h.p.i. that PPMO treated infected cells only
produced approximately 10% of all viral mRNA, except for L which produced
almost 50% viral mRNA compared to the control sample.
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Notably, the longer infection progressed, the more dramatic the effect of M
knockdown had on the efficiency of viral mRNA production. By 24 h.p.i., there was
at least a 94% decrease in mRNA production per gene, contrasted with the 6-hour
time point, where we observed up to a 75% decrease in mRNA production. Unlike
with viral mRNA, host mRNA remained unchanged throughout the time course
infection, indicating a specificity of the M PPMO knock-down in targeting viral
mRNA production. Additionally, as a representative of viral genomic (v)RNA, we
similarly tested the expression of P vRNA in response to PPMO during infection.
Our results show that vRNA production was ablated in response to PPMO
treatment (Figure 4.8 D), whereas the control cells continued to produce vRNA
during infection as previously reported [120]. Taken together, these data suggest
that the presence of M during infection has a significant impact on establishment
of infection by positively affecting viral transcription and replication.
PPMO knockdown of M results in changes of inclusion localization during
infection
IBs are sites of efficient viral replication and transcription. For HMPV, they
coalesce in an actin-dependent manner during infection, a process which is
postulated to increase viral genomic and mRNA production [120]. Moreover,
several NNS RNA viral M proteins are known to interact with viral RNPs, priming
them for assembly at the plasma membrane [44, 186]. Since our current data
suggest that HMPV M informs early infection events, we sought to understand
whether M affects replication and transcription by influencing inclusion body
morphology and localization. To address this, we performed IF combined with
fluorescence in situ hybridization (FISH), using probes specifically designed to
detect the vRNA species in cells during a time course infection as previously
designed

[120].

Using

two

physiologically

relevant

cell

types;

human

adenocarcinoma alveolar basal epithelial cells, A549 [206], and non-tumorigenic
human bronchial epithelial cells BEAS-2B [207], we addressed the formation of
inclusion bodies with and without M PPMO treatment (Figure 4.9). We observed
that during time course of infection, as previously reported [120], HMPV IBs
coalesce over time, forming larger perinuclear inclusions. By 18 h.p.i. in BEAS-2B
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cells, the N protein, which is a critical component of viral ribonucleoproteins, forms
filamentous structures (Figure 4.9 B), consistent with previous reports showing that
M and N associate at the plasma membrane within cell-associate branched
filaments and within budding filamentous viral particles [208, 209]. We also
observed that by 24 h.p.i., N and vRNA were present in intercellular extensions,
corroborating a previously observed result [208]. Conversely, for our time course
data on M-PPMO treated cells, we were unable to identify N or vRNA in
filamentous structures in both cell types. Moreover, IBs and vRNA appeared to be
confined to the perinuclear region even at later time points (18 and 24 h.p.i.),
suggesting a deficiency in trafficking to the plasma membrane. Together, these
data indicate that HMPV M is an important mediator in trafficking vRNA to the
plasma membrane. It still remains unclear whether blockade of vRNA movement
to the plasma membrane as a result of M knockdown is linked to the reduction in
transcription and replication, as reduced levels of other viral proteins could also
influence vRNA trafficking.
Mutations to the calcium binding site of HMPV M effect protein
conformation
Our studies of the matrix protein sought to understand how its unique
features such as nuclear sojourn and calcium binding potentially effect HMPV
infection. To this end, we also investigated the effect of mutating calcium
coordinating residues. Leyrat et al. previously published a high-resolution crystal
structure of HMPV M, which to date is the first NNS RNA matrix protein to have
been co-crystalized with calcium. They identified residues E24, D26, L28, and
K101 as directly forming a pentavalent interaction to secure calcium binding within
the N-terminal region of each HMPV M monomer [83]. To examine the potential
role of calcium binding for HMPV M, we made individual alanine substitutions to
each calcium coordinating residue listed above, including E103, an adjacent
residue to the calcium binding site. In addition, we created a quadruple mutant
which featured all four calcium binding proteins mutated to alanine (Figure 4.10 A).
Our initial interest with these mutants was to investigate whether removal
of calcium-coordinating residues potentially affected the localization of the matrix
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protein when transfected into cells. Our results show that mutagenesis of the
calcium binding site does not result in abberant localization; WT M and mutants
were similarly distributed throughout the cell (Figure

4.10 B). To quantify the

expression of mutants relative to WT, we expressed plasmids containing WT M or
each mutant listed in Figure 4.11 A in A549 cells, and performed Western blotting.
Our results support our initial finding with IF that all the mutants are detectable,
and none of the mutations in residues that are involved in the direct interaction with
calcium significantly change expression profiles (Figure 4.11).
Using a thermal shift assay, Leyrat et al. demonstrated that removal of
calcium resulted in a 25ºC shift in melting temperature, showing that the binding of
calcium to HMPV M increases thermostability and potentially contributes to its
structural rigidity [83]. We were interested in testing whether this calcium binding
also affected the conformation of the matrix protein when expressed in a cellular
environment. To address this question, we performed radioimmunoprecipitation
studies on WT M along with its mutants using a polyclonal avian metapneumovirus
C matrix antibody that cross-reacts with HMPV M. This polyclonal antibody works
well for Western blotting, which requires antibody interactions with a denatured
protein, supporting the idea that this polyclonal antibody can recognize sequencespecific epitopes. We contrasted this with radioimmunoprecipitation studies
performed with the conformation specific anti-HMPV M monoclonal antibody JOJ,
which is conformational specific, as shown by its lack of reaction in Western
blotting applications. Our data show that mutants of E24A, D26A, L28A, K101A,
and the 4A mutant, M no longer binds the conformational antibody, but maintain
binding to the sequence-specific antibody (Figure 4.12). Interestingly, we noted
that the L28A and 4A mutants produced higher molecular weight M species (Figure
4. 12), suggesting that L28 potentially plays a role in regulating M oligomerization.
Additionally, the mutant E103A, which is proximal to the calcium binding site but
not directly involved in calcium binding also was able to bind the sequence-specific
antibody, providing evidence that the calcium coordinating residues in particular
are responsible for the maintenance of the matrix protein structure at the calcium
binding site.
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Discussion
Traditionally, our understanding of NNS RNA matrix proteins have centered
on their roles in the assembly, budding, and egress of viral particles—much of
which occurs at during late stages of infection [44, 186]. NNS RNA viral M proteins
are known to form a highly ordered layer underneath the plasma membrane,
inducing membrane curvature and facilitating the budding of new viral particles [83,
191, 192]. However, more recent reports document characteristics of M that
suggest roles in addition to its mediation of late-stage infection. For example,
henipavirus matrix proteins are imported into the nucleus and then exported before
they arrive at the plasma membrane for assembly. For HeV M, the positive charge
at position 258 is critical for nuclear transit, and specifically, the K258 residue must
be ubiquitinated before the protein can exit the nucleus and associate with
membrane structures [96, 194]. Both of the HeV M mutations that prevented either
nuclear entry or nuclear exit also failed to associate with the plasma membrane
and prevented virus budding and egress [96]. Although the lack of cytosolic
distribution of nuclear-accumulated M provides a straightforward explanation for
the lack of membrane association, it is less clear why mutations that prevented the
import of M into the nucleus also result in a similar deficiency in assembly, since
M was readily available in the cytosol. The authors speculate that in addition to
monoubiquitination, M must form important associations within the nucleus that
enable subsequent membrane association to occur [96].
As previous studies show that several NNS RNA viral matrix traffic to the
nucleus, and our IP/MS data suggested that HMPV M associates with Ran, a
nuclear GTP factor, we probed whether HMPV M also demonstrated nuclear entry
during infection. Our results show that between 6 and 12 h.p.i., HMPV M is mainly
localized within the nucleus, and by 18 - 24

h.p.i., becomes associated in

filamentous structures consistent intercellular extensions and budding filamentous
virions [208]. Previous studies of HMPV, HeV, and NiV show that when transfected
alone, HMPV and henipavirus M do not demonstrate the same degree of steadystate nuclear retention that we observed for infection [96, 210, 211], indicating that
infectious conditions promote nuclear accumulation, especially early in infection.
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Interestingly, we note that the nuclear entry of the HMPV matrix protein coincides
with the timing of exponential HMPV replication and transcription that was
previously reported [120]. Our minireplicon system showed that the presence of M
had a moderate yet significant inhibitory effect on HMPV minigenome replication
and transcription, and thus led us to hypothesize that one consequence of HMPV
M sequesteration in the nucleus is to curtail inhibition of efficient replication and
transcription of the viral genome. An extension of this hypothesis is that the timely
export of M would then inhibit viral replication and transcription, to favor assembly
at the plasma membrane.
Infection with recombinant Sendai virus (SeV) recombinant NiV,
recombinant measles virus (MeV), and recombinant RSV, all lacking M, or SeV
infection with siRNA knockdown targeted against M show severe deficits in
assembly and budding, but no significant effects in replication and transcription in
cases where they were assessed [212-216]. Interestingly, when mutants were
created to block NiV M from exiting the nucleus, NiV M was also found to be
present in perinuclear IBs. The presence of NiV M presumably occurred before
nuclear import, and inclusion bodies formed in this manner were hypothesized to
be aggresomes [217]. Moreover, RSV lacking M results in N retention in IBs, and
prevention of viral filament maturation [216]. Although the effects of M during early
infection of the paramyxovirus SeV suggest that M does not affect replication and
transcription during infection [214], studies on RSV show changes to IBs in the
absence of M [216] and direct quantitation of viral genome and mRNA in response
to M depletion had not yet been investigated in pneumoviruses until this study. Our
knockdown of M resulted in considerable decreases in viral transcription and
replication. We found that along with M knockdown was an accumulation of Ncontaining inclusion bodies at the perinuclear region, similar to results obtained for
RSV [216].
Based on the interaction of M with RNPs previously discussed, it was not
surprising that knocking down M would reduce the placement of N and IBs at sites
closer to the plasma membrane; however, our unexpected observation of a large
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decrease in efficiency of viral replication and transcription after M knockdown
suggests a potential link between inclusion body dynamics mediated by M and the
efficiency of vRNA and viral mRNA production. Previously, our group has shown
that IBs interact with actin during infection to coalesce and boost replication and
transcription [120]. During infection, M localizes within branched filamentous
structures, which are also populated with actin. Actin remodels cells for efficient
viral transmission [208]. It is possible that HMPV M makes contact with both actin
and vRNP during infection to mediate trafficking of vRNPs to the plasma
membrane for assembly. In terms of how this potentially contributes to the
efficiency of viral replication, the trafficking of vRNPs away from their sites of
synthesis may prevent overaccumulation of vRNPs. Indeed, recent data has
shown that NiV IBs can act as aggresome-like compartments [217]. If this also
occurs for HMPV inclusions in the context of overaccumulation of viral proteins,
lack of trafficking of N and vRNA from IBs could inflict deleterious effects on proper
IB replication and transcription function.
We cannot rule out that HMPV M contributes to the regulation of replication
and transcription while it is within the nucleus. HeV M, NiV M, NDV M, SeV M, MeV
M, canine distemper virus (CDV) M, influenza A, and influenza B (IAV and IBV)
polymerase proteins have been shown to interact with acidic leucine-rich nuclear
phosphoprotein 32 family member B (ANP32B). [210, 218-221]. ANP32B is critical
for host range determination of IAV and IBV [218, 220]. Interestingly, its interaction
with henipavirus M drives an increase in steady-state nuclear accumulation of
ANP32B. It has been proposed that henipaviral M associations with ANP32B may
help with nucleocytoplasmic shuttling or with inhibiting host responses to favor viral
infection [210]. Moreover, recently, ANP32B was found to regulate immune
responses in mice [222]. Although not found to directly interact with bovine RSV
M, ANP32B can indirectly interact with proteins through CRM1, an adaptor protein
for CD48 mRNA transport, further implicating M in associations with immune
response modulators [221, 223]. The CRM1 protein has been identified to mediate
nuclear shuttling of RSV M [199]. With HMPV M being closely related to RSV M, it
is possible that CRM1-mediated interactions with either CRM1/CD48 mRNA
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and/or ANP32B and potential downstream effectors occur during infection. Followup studies with IP/MS of nuclear-isolated M, in addition with chromatin
immunoprecipitations (ChIP), would be helpful in identifying unique nuclear
interactors and would enhance our understanding of the roles of HMPV M. In
addition, with M postulated to interact with cytoplasmic tails of surface
glycoproteins [44, 186], although our data show that the fusion protein is
decreased in response to M knockdown, further investigation into the proportion of
surface-exposed M and F would contribute to our understanding of HMPV M in
viral assembly.
Our data also show that although mutations to the calcium binding region of
HMPV M do not affect cytosolic localization, there is a difference in folding (Figure
4.11), although it is not known whether this difference in folding is specific to the
calcium binding portion of the protein only, or whether it affects the ultrastructure
of the protein, as the recognition site for the antibody is currently unknown. Follow
up studies involving crystallization of the mutants are necessary to validate lack of
calcium interaction, as well as changes in conformation. These results build on the
previous finding that HMPV calcium binding increases thermostability [83],
suggesting that the conformational changes contribute to the decrease in
thermostability as a result of a lack of calcium binding.
HMPV M makes contacts with the membrane using its concave surface and
the calcium binding pocket sits at the convex surface [83]. Although I hypothesize
that conformational changes conferred by calcium binding likely most affect the
concave surface, given its proximity to the calcium binding site, it would be
important to examine whether calcium binding affects membrane association by
transmitting additional conformational changes either throughout the protein or
facilitates changes in interactions with currently unidentified membrane proteins
and/or lipids. Moreover, the residues in HMPV M which potentially engage in
contact with actin and/or vRNP association for assembly occur are currently
unknown. In addition, there is a gap in our knowledge of whether HMPV M, like
EBOV VP40, binds RNA directly [224]. It may be that the because the calcium
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binding site, a cationic site, facing away from the membrane towards the cytosol,
would mediate interactions with negatively charged molecules such as RNA.
Finally, the role of calcium binding in maintaining the structural integrity of nascent
virions is worth investigating.
Taken together, our data supports a model where while in the cytosol, HMPV
M associates with actin to recruit vRNPs from IBs to the membrane, and
recruitment of vRNPs to the membrane plays a role in maintaining the homeostasis
required for efficient vRNA and viral mRNA production. This effect of maintaining
inclusion body homeostasis is particularly pronounced during mid-to-late stages of
infection, when IBs coalesce in an actin-dependent manner, and reach maximal
transcription and replication activities. This potentially works synergistically with
nuclear HMPV M, which could interact with (a) nuclear factor(s) to mediate cellular
responses that are otherwise detrimental for viral infection. In addition, calcium
binding of HMPV M facilitates necessary conformation of M to mediate its multitude
of functions.
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Table 4.1 List of host cell proteins associated with the HMPV matrix
protein.
Reference
sp|P23396|RS3_HUMAN

Gene
Symbol
RPS3

sp|P42704|LPPRC_HUMAN
sp|P62070|RRAS2_HUMAN

LRPPRC
RRAS2

sp|O95831|AIFM1_HUMAN
sp|P07437|TBB5_HUMAN
sp|P68366|TBA4A_HUMAN
sp|P10301|RRAS_HUMAN

AIFM1
TUBB
TUBA4A
RRAS

sp|Q8NHP6|MSPD2_HUMAN
sp|P62269|RS18_HUMAN
sp|P62829|RL23_HUMAN
sp|P62263|RS14_HUMAN
sp|P35244|RFA3_HUMAN
sp|P23284|PPIB_HUMAN
sp|P42677|RS27_HUMAN
sp|Q96CJ1|EAF2_HUMAN
sp|P12236|ADT3_HUMAN
sp|P78347|GTF2I_HUMAN
sp|Q13509|TBB3_HUMAN
sp|Q15165|PON2_HUMAN
sp|P62826|RAN_HUMAN

MOSPD2
RPS18
RPL23
RPS14
RPA3
PPIB
RPS27
EAF2
SLC25A6
GTF2I
TUBB3
PON2
RAN

sp|Q00325|MPCP_HUMAN

SLC25A3

sp|O14983|AT2A1_HUMAN
sp|P07900|HS90A_HUMAN
sp|P62249|RS16_HUMAN

ATP2A1
HSP90AA1
RPS16

sp|P15559|NQO1_HUMAN

NQO1

sp|P51114|FXR1_HUMAN
sp|P62820|RAB1A_HUMAN
sp|P46781|RS9_HUMAN

FXR1
RAB1A
RPS9

sp|Q8TF66|LRC15_HUMAN

LRRC15

sp|Q58FF8|H90B2_HUMAN

HSP90AB2P

sp|P29966|MARCS_HUMAN
sp|P68363|TBA1B_HUMAN
sp|P62834|RAP1A_HUMAN

MARCKS
TUBA1B
RAP1A

Spectral
Protein
Count
40S ribosomal protein S3
17.1
Leucine-rich PPR motif-containing
protein, mitochondrial
5.2
Ras-related protein R-Ras2
4.7
Apoptosis-inducing
factor
1,
mitochondrial
4.5
Tubulin beta chain
4.2
Tubulin alpha-4A chain
4.1
Ras-related protein R-Ras
3.3
Motile sperm domain-containing
protein 2
2.9
40S ribosomal protein S18
2.8
60S ribosomal protein L23
1.8
40S ribosomal protein S14
1.7
Replication protein A 14 kDa subunit 1.6
Peptidyl-prolyl cis-trans isomerase B 1.3
40S ribosomal protein S27
1.1
ELL-associated factor 2
1
ADP/ATP translocase 3
1
General transcription factor II-I
1
Tubulin beta-3 chain
1
Serum paraoxonase/arylesterase 2
1
GTP-binding nuclear protein Ran 1
Phosphate
carrier
protein,
mitochondrial
1
Sarcoplasmic/endoplasmic
reticulum calcium ATPase 1
1
Heat shock protein HSP 90-alpha
1
40S ribosomal protein S16
1
NAD(P)H
dehydrogenase
[quinone]c 1
1
Fragile X mental retardation
syndrome-related protein 1
1
Ras-related protein Rab-1A
1
40S ribosomal protein S9
1
Leucine-rich
repeat-containing
protein 15
1
Putative heat shock protein HSP 90beta 2
1
Myristoylated alanine-rich C-kinase
substrate
1
Tubulin alpha-1B chain
1
Ras-related protein Rap-1A
1

Cells were transfected with HMPV M and subjected to poly(I:C) treatment to mimic
viral infection. Interactome includes Ran, a GTP-binding nuclear protein that is
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associated with nucleocytoplasmic transport. This data was generated by Dr.
Gaya Amarasinghe (Washington University in St. Louis).
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Figure 4.1. Localization of human metapneumovirus matrix protein (HMPV
M) during infection.
BEAS-2B cells were infected with HMPV at multiplicity of infection (MOI) of 4. Cells
were fixed at 6, 10, 12, 18, 24, and 30 hours post infection (h.p.i) for
immunofluorescence with the monoclonal anti-HMPV antibody JOJ x (A-F).
Colocalization profiles of DAPI, representing nuclei, and HMPV M (red; G-L).
Images were taken with a Nikon A1 confocal microscope. Images are
representative of at least 10 images taken for each condition. Scale bars represent
10µm.
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Figure 4.2. HMPV Matrix protein effect on minigenome activity.
BSR cells constitutively expressing T7 polymerase were transfected with HMPV
N, P, L, M2-1, and a luciferase-encoding minigenome. Altogether, these
components termed here as the luciferase minigenome system. In the context of
varying HMPV matrix (M) concentration (0.2 - 2µg), the minigenome reporter
activity was examined. Experiment was performed in triplicate. n=1. Two-way
ANOVA was performed to assess significance. *p<0.05, **p<0.005, ****p<0.0001
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Figure 4.3. Peptide-linked phosphorodiamidate Morpholino oligomer (PPMO)
mechanism of action.
A. Consensus sequence generated based on cDNA of first 25 nucleotides (13
nucleotides comprising of the 5’untranslated region, and the first 12 nucleotides of
HMPV coding region) based 44 disparate HMPV strains. Accession numbers and
individual sequences included in appendix. B. Antisense PPMO generated based
on consensus sequence, with particular emphasis on HMPV M strain CAN97-83
(GenBank accession number AY297749.1). C. Simplified mechanism of viral
translation initiation by cellular ribosomal machinery in absence of PPMO. Small
ribosomal subunit containing t-RNA scans 5’ untranslated region (UTR) for start
codon. After initiation, elongation occurs, allowing for the translation of mRNA into
viral proteins. D. PPMO hybridize to 5’UTR of HMPV M, sterically blocking access
of small ribosomal subunit from the start codon. Translation is not initiated, and M
protein is knocked down.
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Figure 4.4. Sequence alignments of designed PPMO on 5’untranslated
regions of HMPV genes.
A. Sequence alignment of scrambled (nonsense PPMO with no known cellular or
viral targets) antisense PPMO target sequence against viral genes. B. Sequence
alignment of antisense PPMO target (M) against 5’untranslated regions of other
viral genes. C. Percent identity matrix of Scrambled and M-specific gene targets.
All analyses were performed using ClustalW2
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Figure 4.5. Cell viability after exposure to varying concentrations of the
PPMO.
Results of a flow cytometry experiment on A549 cells treated with indicated
concentrations of scrambled PPMO (blue) or M-specific PPMO (red). Cell viability
was assessed with propidium iodide. The experiment was carried out in duplicate.
n=1.
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Figure 4.6. Expression of HMPV viral proteins after PPMO treatment.
A. A549 cells were treated with either 5 µM of scrambled PPMO (-PPMO), or 5 µM
of

M-specific

PPMO

(+PPMO).

PPMO

were

added

at

0

h.p.i.

Radioimmunoprecipitation of cell lysate collected at indicated times show matrix
protein (F) expression during infection with and without M-specific PPMO
treatment. B. A549 cells treated with or without M-specific PPMO were assessed
for fusion protein (F) expression in time course. C and D, quantitation of A and B.
The experiments were carried out in duplicate. n=2
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Figure 4.7. Effect of HMPV M-targeting PPMO on HMPV, PIV5, and RSV.
A549 cells were infected with either rgHMPV, rgPIV5, or rgRSV at a multiplicity of
infection (MOI) of 4. Cells were either treated with 5 µM of scrambled PPMO (PPMO) or 5 µM of HMPV M-targeting PPMO (+PPMO) at indicated times post
infection. Cells were visualized at 24 hours post infection (h.p.i.) (A-C) Images
were acquired with a Zeiss Axiovert 100 microscope. Scale bars represent 50 µm.
Images are representative. D-F flow cytometry to quantify infection of cells in A-C.
A-C were carried out in duplicate, n=2. Flow cytometry was performed in duplicate;
n=1.
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Figure 4.8. Quantitation of viral genomic (v)RNA and viral mRNA following
M-targeting PPMO knockdown.
A-C. A549 cells were infected with WT HMPV at an MOI of 4. At 0 h.p.i, cells were
treated with either 5 µM of scrambled PPMO (-PPMO-M) or 5 µM of M-targeting
PPMO (+PPMO-M). RNA was isolated for quantitative RT PCR at indicated time
points. In addition to viral mRNA, host cellular actin and GAPDH mRNA expression
levels were also examined. D. Effect of PPMO treatment as performed in time
course for A-C was also performed using primers against vRNA. The experiment
was carried out in triplicate. n=1. This experiment was performed by Dr. Chengyu Wu.
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Figure 4.9. Effect of M-targeting PPMO on inclusion body localization.
A549 (A) and BEAS-2B cells (B) were infected with WT HMPV at an MOI of 4. At
0 h.p.i, cells were treated with either 5 µM of scrambled PPMO (-PPMO) or 5 µM
of M-specific PPMO (+PPMO). Cells were fixed in 4% PFA at indicated times post
infection and visualized using a Nikon A1 confocal microscope. Scale bars
represent 10 µm. Images are representative. C. Quantitation of distance of IBs
from nuclei in absence or presence of M-specific PPMO of at least 10 cells per
condition. Experiments and figure preparation of A and C were performed by
Dr. Cheng-Yu Wu.
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Figure 4.10. Effect of mutating calcium-coordinating residues on HMPV M
localization.
A. Schematic of mutations performed to the calcium binding site of HMPV M. B.
Immunofluorescence images taken with a Nikon A1 confocal microscope, showing
localization of HMPV M mutant proteins compared to wild type (WT). Scale bars
represent 10 µm. Images are representative. n=1
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Figure 4.11. Effect of mutagenesis of calcium coordinating mutants on
HMPV M expression.
A. Western blot from cell lysates of cells transfected with HMPV M. B. Quantitation
of A with standardization to tubulin. n=2
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Figure 4.12. Radioimmunoprecipitation of HMPV M following mutagenesis to
calcium binding site with conformational and sequence-specific antibodies.
A. Detection of immunoprecipitated WT HMPV matrix protein sequence-specific
and B. conformation specific antibodies. Experiments were performed in triplicate.
n=1.
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Chapter 5 :DISCUSSION AND FUTURE DIRECTIONS
Overview
Generating effective preventative and treatment measures to battle viral
infections requires a thorough understanding of the molecular details of viral
infection. The work in this dissertation focuses on infectious mechanisms of nonsegmented negative sense (NNS) RNA viruses with particular emphasis on the
factors that govern the mechanisms of viral entry facilitation. In addition, this work
addresses an unlikely key player in early infection, and how it may function in
eventually generating viral progeny. Previous studies on paramyxo- and
pneumoviruses that have focused on how viral fusion (F) and attachment proteins
(G) start infection established the foundation for the first part of this dissertation
work. These have provided a basis for our understanding that the F protein is
triggered in a timely manner to mediate the merger of the viral and target cell
membranes. The factors that contribute to the metastability of the F protein before
it is triggered include a transmembrane domain (TMD) that trimerizes with the help
of a leucine/isoleucine (L/I) zipper. For Hendra virus (HeV), the L/I zipper is critical
for the proper expression of HeV F in its fusogenically active form. In Chapter 3,
we address whether this observation is relevant within the paramyovirus family by
studying the TMD L/I zipper in the context of another paramyxovirus, parainfluenza
virus 5 (PIV5). We establish that the TMD L/I zipper does not affect the surface or
total expression of PIV5 F, but it is key in its functionality. This thesis also includes
the study of a pneumovirus, human metapneumovirus (HMPV), and the early
events after entry. In Chapter 4, the effects of the viral matrix protein, traditionally
thought to be solely a major drive of events associated with late infection, are
discussed in the context of establishing infection. This work has identified potential
additional roles of the matrix protein in promoting efficient viral replication and
transcription. This work contributes to our understanding of NNS RNA viruses but
also highlights unanswered questions that would contribute to understanding the
molecular basis of infection for identification of new antiviral targets.
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Transmembrane domain interactions facilitate functionality of
paramyxovirus fusion proteins.
Enveloped viruses require carefully orchestrated events to merge their
membranes with host cell membranes. Membrane mergers are processes that
require repulsive “hydration forces” to be overcome in a kinetically costly process,
as distinct membranes approach each other. Viral surface glycoproteins provide
the basis through which membrane mergers occur between viruses and their target
cells [225]. Paramyxoviruses and the closely related pneumoviruses typically
engage attachment proteins for adsorption of viral particles to host cells. They also
possess fusion proteins which undertake a major part of the membrane merging
process by undergoing dramatic conformational changes down an energy
gradient. Proper functionality of these surface glycoproteins serves as a critical
jumping point of establishing viral infection [44, 134, 186].
Paramyo- and pneumoviral fusion proteins are classical class I fusion
proteins: they fold into homotrimers within the endoplasmic reticulum, require a
cleavage process to expose their fusion peptide before they become functionally
active, and refold portions of their ectodomain into a six-helix bundle of α-helices.
Importantly, these proteins are held in a metastable conformational state until the
signal for triggering occurs [226]. Initial contacts during the fusion process involve
fusion protein ectodomains, thus implicating them as important players in driving
membrane merging [53, 143]. As such, the fusion peptides and heptad repeat
regions have been heavily probed as therapeutic targets. The HIV drug Enfuvirtide,
is a robust example of the outcome of such works. Enfuvirtide is an HR2-derived
peptide that outcompetes HR2 to bind the HR1 of gp41, blocking progression of
the fusion protein from its pre-hairpin intermediate to the six-helix bundle form
[227]. In addition, peptides directed at the heptad repeats of henipaviruses,
measles virus (MeV), and RSV have shown promise [228-230].
Given the complexity of the membrane fusion process, it is important that
all domains of fusion proteins are well studied if effective targets are to be
generated. While the external domains of fusion proteins have been historically
examined, it was not until recently that these studies extended to their
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transmembrane domains [231, 232]. Their hydrophobicity makes TMDs difficult to
crystalize; however, development of potent biochemical assays has allowed the
scientific community to piece together important features of fusion protein TMDs
that affect functionality [231]. One of the most widely studied class I fusion proteins
is influenza HA. Reports document that replacement of the HA TMD with a
glycosylphosphatidylinositol (GPI) anchor resulted in loss of HA functionality in
merging membranes. Specifically, the influenza HA-GPI chimeric protein was only
able to partially drive membrane fusion, resulting in hemifusion, a process where
the outer and not inner membrane leaflets fuse [233, 234]. These studies
suggested a potential role of the length of the TMD, and its spanning across both
leaflets as important in completion of membrane fusion. Indeed, when the TMD
was truncated, influenza HA also formed a hemifusion intermediate [235].
Moreover, VSV G, which is a class III fusion protein also demonstrated a length
requirement for proper fusogenic activity—truncation mutants similarly resulted in
hemifusion intermediates [235]. In addition to length, recent work demonstrates
that the dissociation of the trimeric TMDs of HeV F is required to facilitate fusion.
Introduced disulfide bonds to the N-terminus of the TMD that locked the TMD in
trimeric state resulted in loss of fusion activity, despite some of the mutants being
expressed at surface levels sufficient for fusion [236]. Similarly, experiments were
carried out with PIV5 F, where the membrane proximal external region (MPER)
was locked together using introduced disulfide bonds. The data from this work also
shows that dissociation of trimeric interactions is important for F fluidity and
subsequent transitions from pre-to-post-fusion conformation [237].
In the VSV G example listed above where truncation resulted in loss of
functionality, a single glycine residue reintroduced to the truncation mutant
restored 80% functionality. This example is one of the studies that showed that the
specific amino acids present in the TMD are critical for its function [238]. The
potential importance of individual residues in the context of viral fusion protein
TMDs therefore spurred follow up studies from several groups that identified
specific amino acids within individual fusion proteins as playing a role. Using
sedimentation equilibrium ultracentrifugation, our lab determined that in isolation,
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the transmembrane domains of several class I and class II fusion proteins trimerize
[41, 145]. The presence of an AXXG motif within the TMD of HeV F led to an
investigation of whether this motif plays roles in trimerization and fusogenic activity
of the full protein. This work showed that upon mutation of the AXXG glycine
residue, G508 to alanine, leucine, or isoleucine, the surface expression and
fusogenic activity were reduced. Interestingly, it was found that these mutations
strengthened TMD-TMD interactions, thus pointing to a role of the G508 in
maintaining protein expression and functionality [41]. The recent work on the
locking of TMDs in trimers using disulfide bonds demonstrated that the mutant F
proteins lost fusogenic activity, but where able to undergo at least initial triggering
of conformational changes, as they lost binding to a pre-fusion specific antibody.
[236]. Together, these studies indicate a requirement of flexibility in TMD trimeric
interactions underline a very delicate balance in the triggering of fusion proteins.
The presence of a proteinaceous TMD is required for trimerization of the
protein, with specific residues playing key roles. But what is the nature of residues
that support the maintenance of the metastable pre-fusion structure such that it
can still be triggered when signaled? On investigation of other potential interaction
motifs within the TMD, a leucine/isoleucine (L/I) zipper in frame with the heptad
repeat B L/I zipper was identified [66]. On further investigation, this L/I zipper or
similar repeats of β-branched residues were identified in TMDs of 140 other
paramyxo-and pneumovirus F proteins, suggesting a conserved importance
across the viral families. Studies with HeV F identified the L/I zipper as critical in
pre-fusion stability of the protein, as mutations to the L/I zipper resulted in
misfolding and loss of functionality. In isolation, the TMD of HeV F was found to
associate in trimers as determined by sedimentation equilibrium analytical
ultracentrifugation (SE-AUC) [74].
In chapter 3, we addressed the L/I zipper of another paramyxovirus F
protein, parainfluenza virus 5, a paramyxovirus model system. Previously, the L/I
zipper of HeV F was found to be important for properly maintaining prefusion
conformation. Surface biotinylation experiments elucidated a reduction surface
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expression of the L/I zipper mutant, suggesting a role for the L/I zipper in proper
folding and/or trafficking the fusion protein. Our initial experiments visualized the
placement of HeV F, and found that as suspected, the decrease in HeV F surface
expression was because it was retained in structures close to the nucleus
consistent with the endoplasmic reticulum (ER). ER retention reflects a defect in
folding, which can lead to degradation in the unfolded protein response pathway
[239], thus explaining the decrease in overall protein expression for HeV F L/I
zipper mutants. The previous analytical ultracentrifugation data, together with the
surface biotinylation and immunofluorescence data, show that the TMD L/I zipper
strongly impacts trimerization of the protein as it is being synthesized, and that
disruptions of these TMD L/I zipper interactions causes adverse effects during the
very early stages following synthesis. In Chapter 3 our paramyxovirus model
conversely suggests that the L/I zipper is not critical for surface expression in PIV5,
as IF and surface biotinylation data show only a modest decrease in surface
expression following mutations to the L/I zipper. We also used a conformationspecific antibody to show that L/I zipper mutants were still stable in the prefusion
form, and thermal triggering assays demonstrated a loss of prefusion conformation
after exposure to heat, indicating that these mutants are capable of being
triggered.
Despite the difference in effects of the TMD L/I zipper on surface expression
between HeV F and PIV5 F, an interesting parallel exists for these proteins: the L/I
zipper contributes to the functionality of the F protein. In Chapter 3, we showed
using syncytial and reporter gene assays that, despite the presence of the mutants
on the surface in pre-fusion form and despite the ability of these mutants to be
triggered, TMD L/I zipper mutations rendered the protein non-functional. Our work
corroborates a previous study that showed that one of the leucine residues present
in the L/I zipper, L486, is an important driver of fusion. Further mutagenesis work
in dissecting the individual roles of the other L/I residues within the zipper would
enhance our understanding of the strength of these interactions in the context of
functionality. It would be important to also examine PIV5 F L493, and PIV5 F L500
independently for surface expression, syncytial formation and fusogenic activity in
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a reporter gene assay. Given that our triple mutant, L486A + L493A + L500A
readily expresses its pre-fusion form on the surface of cells, I hypothesize that with
each of these individual mutants, there would not be severe deficits in surface
expression and should facilitate functional studies. Within the L/I zipper, the
position at 507 is a valine residue. Mutating this residue to alanine, leucine or
isoleucine in the context of the wild type protein would also be important to include
in the study of how these residues affect protein functionality. Additionally, like the
G508 example for HeV F [41], it would be important to perform single and
combination mutagenesis on isolated TMDs of PIV5 F for TMD-TMD oligomeric
analyses. These studies would be helpful in investigating the mechanisms through
which L/I zippers contribute to functionality through the lens of TMD associations.
Although our study identified that fusion is blocked when the L/I zipper is
mutated to alanine, we are limited in our knowledge of the stage of fusion that is
affected. Weakened interactions of the TMD could result in prematurely triggered
F; however, our results in Chapter 3 that show only a modest decrease in prefusion F at the surface of cells in response to L/I zipper mutations, refuting this
idea. Moreover, Chapter 3 shows that F loses binding affinity to the pre-fusion
conformational antibody upon triggering, suggesting that F is at least able to start
the triggering process in absence of the L/I zipper. These observations beg the
question of how fusion is then prevented in the TMD L/I zipper PIV5 mutants.
Studies show that the TMD forms critical interactions with HN to secure the
formation of the six-helix bundle. Further studies addressing whether a post-fusion
F can be formed, whether a six-helix bundle can be formed, or alternatively
studying the presence of pre-fusion intermediates in absence of the L/I zipper will
assist in our understanding of the L/I zipper function.
Therapeutic targeting of paramyxo- and pneumovirus fusion
transmembrane domains
As with the Enfuvirtide example of a designed peptide inhibiting fusogenic
activity [227], our lab group recently generated an exogenous HeV TMD-based
peptide. The rationale behind this approach is that an exogenous TMD peptide
would outcompete and displace native TMD trimerization, resulting in the
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premature triggering or misfolding of the full protein. When examined, coexpression of HeV F with the HeV F TMD-targeted peptide resulted in reduction in
F protein expression and fusogenic activity. Co-expression of peptides designed
against PIV5 F TMD did not inhibit HMPV infection, although significantly reduced
PIV5 F infection, suggesting sequence specificity as a factor [146]. These
promising data suggest that in addition to ectodomains, the TMDs of viral fusion
proteins potentially present as potent drug targets.

The HMPV matrix protein in early infection
Once entry is successfully executed, enveloped viruses release their
contents into host cells for propagation. As discussed in the introduction (Chapter
1), HMPV induces formation of inclusion body structures, where the bulk of
replication and transcription events of viral genes occur. Once genes are
translated, the viral proteins are assembled at the plasma membrane, during what
is termed late-stage infection for budding and egress. The matrix protein has been
postulated for many viruses to be the main organizer of assembly, budding and
egress [44, 193]. Although HMPV M is not involved in the ESCRT pathway, there
is a conserved YAGL motif that facilitates higher order oligomerization necessary
for the formation of the grid-like array underneath the plasma membrane that
enables viral assembly and budding [211]. Like the Ebola virus (EBOV) VP40
matrix protein, transiently expressed in 293-F cells, HMPV M has been reported to
form virus-like particles (VLP)s [240].
Since its discovery in 2001, there have been a limited number of studies on
functions of the HMPV matrix protein; however, closely related viral matrix protein
functions may shed light on some of the unknown functions of HMPV M. Despite
low sequence similarity among Mononegavirales, there is a high degree of
structural similarity (Chapter 1), suggesting convergent evolutionary mechanisms
in guiding function of the protein. One of the most extensively studied
Mononegavirales matrix proteins is EBOV VP40. EBOV VP40 consists of two
domains: the N-terminal domain (NTD), which is responsible for dimerization of the
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protein, and the C-terminal domain (CTD), responsible for interactions that lead to
and with the plasma membrane [190]. The HMPV matrix protein was also recently
crystalized and similarly shown to have distinct CTD and NTD domains, forming
dimers in solution; however, unlike with EBOV VP40, HMPV M has a dimerization
interface that spans both the CTD and NTDs [83, 190].
Although heavily involved in the processes of assembly and budding, recent
studies have implicated the viral matrix protein in earlier processes during
infection. EBOV VP40 forms an octameric ring that has RNA-binding capabilities,
and when transiently expressed in a reporter gene system, was found to have
inhibitory effects on viral genomic and RNA synthesis [224]. In fact, several
Mononegavirales matrix proteins have either reported associations with RNPs, or
directly with RNA [44, 186], and in some cases inhibit viral replication and
transcription [241-244]; a clue that the viral matrix proteins of these viruses play
key roles at different infectious stages. In chapter 4, we found that like many other
viral matrix proteins, HMPV M first marks its presence in the nucleus shortly after
synthesis, before it traverses to viral filaments. As reviewed in Chapter 1, for NiV
M, this nuclear transit is important for the membrane association and budding
features of M [96, 194]. One important difference between EBOV VP40 and
paramyxo- and pneumovirus matrix proteins is that VP40 contains a series of
hydrophobic residues that deeply penetrate the plasma membrane from the
cytosolic side [245]. The paramyxovirus Nipah virus (NiV) M provides evidence
that at least one Mononegaviral M proteins traffics to the nucleus to gain access
to a currently unknown factor, which may be a posttranslational modification, that
allows for membrane association [194]. In addition, though HMPV M is known to
interact with the viral membrane through its concave surface [83], there is currently
no established posttranslational modification that facilitates the associations of
HMPV M and the viral membrane contrary to what has been observed with EBOV
VP40. Further studies into nuclear isolated M contrasted with cytosol-retained M
may provide further evidence of the nuclear factors necessary for M functionality.
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Similar to EBOV VP40 and MeV M [224, 244], our data in Chapter 4
provided evidence that in a minigenome system, HMPV M exerts inhibitory effects
on vRNA replication and transcription. Surprisingly, in the context of a knockdown,
there were severe deficits in the number of cells where infection had progressed
enough for GFP expression, and with the expression of another viral protein, F.
On further investigation, work in Chapter 4 established that HMPV M positively
contributes to the synthesis of all viral mRNA products as well as to the efficiency
in vRNA production, potentially leading to the observed decrease in HMPV F as a
result of M knockdown. These studies establish a previously unidentified role in
the process of infection of Mononegavirales: M is key in efficient transcription and
translation of viral RNA. The use of a PPMO as a tool for knockdown is extremely
specific [122, 204], and our analyses show no significant homology to the other
genes to allow for cross-reaction of the PPMO with off-targets. However, out of an
abundance of caution, we have designed a second unique PPMO to target HMPV
M. Further studies will examine whether this second PPMO knockdown of M exerts
the same universal effects in viral infection. In addition, extending these
knockdown studies to RSV M would enhance our understanding of the roles
pneumovirus matrix proteins play.
In Chapter 4, we also showed that IB dynamics are severely affected by M
knockdown. When M is knocked down, the movement of IBs and vRNPs towards
the plasma membrane was thwarted. IBs and IB-like structures have long been
studied as critical components of viral replication and transcription, and recent
work from our lab showed that this observation is consistent with HMPV M, with
actin driving coalescence of IBs to promote transcription and replication [120]. A
single-particle tracking study showed that EBOV VP40 traffics along actin towards
the plasma membrane, with plasma membrane contacts serving as an important
modulator of assembly and budding processes [246]. Interestingly, HMPV M has
been shown to associate in branched filaments, and these branched filaments are
at least in part formed through remodeling of actin during infection, suggesting a
potential link between actin and HMPV M. RSV M, Sendai virus M and Newcastle
disease M are also associated with actin, with actin playing positive roles in RNA
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synthesis [247-249]. Further investigations with M and actin would be necessary
to identify whether M acts in concert with actin to positively affect viral RNA
production.
IBs are membrane-less structures and on recent analysis, were shown to
be formed through liquid-liquid phase separation (LLPS), with P as an important
driver of droplet formation. Recent work from our lab group is the first to identify
that HMPV N and P proteins are able to form LLPS, with P as an important driver.
In addition, P forms direct associations with RNA (Boggs, unpublished data). To
carry out these in vitro phase separation assays, our group has developed
protocols for the effective purification of HMPV viral proteins including HMPV M
purification, which is currently being optimized. Future studies will focus on the
effects of HMPV M on the formation of these LLPS structures. In addition, testing
whether HMPV M, like HMPV P, can directly modulate RNA binding would
enhance our understanding of the roles of HMPV M in viral replication and
transcription.
Calcium binding in the functions of HMPV M
Leyrat et al. published in 2014 that HMPV M is a calcium binding protein.
[83]. In Chapter 4, we investigated the role of calcium binding residues in the
expression and folding of HMPV M. We found that single and combination alanine
mutations to the HMPV M calcium-coordinating did not affect expression.
However, we observed loss of conformational antibody binding with alanine
mutants of residues that directly coordinate calcium binding. These studies
suggest that HMPV M calcium binding is essential for proper folding of the protein;
however, our studies are limited as we have not directly shown that these
mutations result in lack of calcium binding. Further studies using purified M or M
mutants could be utilized to verify loss of calcium binding, including and
crystallization of HMPV M mutants would verify whether the changes we observed
result from lack of calcium binding.
Additionally, it would be important to determine the effects of calcium
binding in the context of infection. To examine this, I propose the creation of a
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recombinant virus with M mutants. Since M is heavily involved in budding and
assembly of nascent viral particles, the potential challenge to overcome lies in
whether improperly folded M would yield enough viral titer for subsequent
experiments. In the situation that the recombinant HMPV M cannot be rescued, I
propose transcomplementation of HMPV M either using transient transfection of
plasmid-encoded wild type M, or with a stable cell line that expresses wild type M
for the recombinant calcium-binding-mutant HMPV M viral growth. A similar
strategy was employed for the closely related RSV virus, where M was completely
removed from the genome [216]. Using these recombinant viruses, the effect of
the mutations to the calcium binding residues on nuclear localization, membrane
association, replication, transcription, and inclusion body dynamics could be
studied. In addition, immunoprecipitation coupled with mass spectrometry of
calcium-binding mutants compared to wild type could establish potential host
interactions mediated through calcium binding.
Altogether, the work discussed in this dissertation contribute to our
understanding of NNS RNA

viral infection. Continuing research in the field,

including the outlined future directions would serve to create a framework for
identifying factors that in the long term may serve as effective therapeutic targets.
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Appendix i
Sequences used in the design of M-specific PPMO
ACCESSION #
MF104608.1
MK588635.1
KJ627433.1
KJ627407.1
KJ627427.1
KJ627425.1
KJ627394.1
KY474534.1
AB503857.1
KC403981.1
MH150889.1
KC403979.1
KF686742.1
AY297749.1
KY474537.1
GQ153651.1
MN745084.1
MK087726.1
MN745087.1
MK167039.1
KY474539.1
MF104609.1
MK167040.1
MN306028.1
MN745085.1
MF104602.1
MF104594.1
MF104610.1
KC562233.1
AY530090.1
AY530095.1
KC562221.1
KC562240.1
KJ627417.1
KJ627379.1
KJ627422.1
KJ627430.1
KJ627406.1
KC403978.1
KC403984.1
KC562243.1
MF104611.1
JN184400.1
DQ843659.1

SEQUENCE
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTGAAAATGGAGTCCTAT
GGGACAAGTAAGAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAGTAAAAATGGAGTCCTAT
GGGACAAATAAAAATGGAGTCCTAT
******* * * *************
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Appendix ii
List of abbreviations
6HB
ANP32B
BDV
CD
CDV
ChIP
CPE
CRM1
CT
CTD
EBOV
ER
F
FISH
FP
G/GP
G/GP/H/HN
GPI
H/HA
HeV
HMPV
HN
hpi
hPIV
HRA/B
IAV
IB
IBV
ICAM
IP
JPV
L
LIZ
LLPS
M
M2-1
MDA5
MeV
MOI
MPER
MS
MuV

six-helix bundle
acidic leucine-rich nuclear phosphoprotein 32 family member B
Borna disease virus
cluster of differentiation
canine distemper virus
chromatin immunoprecipitation
cytopathic effects
chromosomal maintenance 1 (exportin 1)
cytoplasmic tail
C-terminal domain
Ebola virus
endoplasmic reticulum
fusion protein
fluorescence in situ hybridization
fusion peptide
glycoprotein
attachment protein
glycosylphosphatidylinositol
hemagglutinin
Hendra virus
human metapneumovirus
hemagglutinin/neuraminidase
hours post infection
human parainfluenza virus
heptad repeat A/B
influenza A virus
inclusion body
influenza B virus
intercellular adhesion molecule
immunoprecipitation
J paramyxovirus
large protein
leucine/isoleucine zipper
liquid-liquid phase separation
matrix protein
matrix 2-1 protein
melanoma differentiation-associated protein 5
measles virus
multiplicity of infection
membrane proximal external region
mass spectrometry
mumps virus
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N/NP
NDV
NES
NiV
NNS
NPC
Npm
NS
NTD
P
PIV5
poly (I:C)
PPMO
PS
RdRp
RIG-I
RNP
RSV
RV
SE-AUC
SeV
SH
SLAM
TGN
TLR 3
TMD
TNF-α
TRV
UBF
UTR
VLP
VP24
VP40
vRNA
VSV
WT

nucleoprotein
Newcastle disease virus
nuclear export signal
Nipah virus
non-segmented negative sense
nuclear pore complex
nucleophosmin
non structural protein
N-terminal domain
phosphoprotein
parainfluenza virus 5
polyinosinic:polycytidylic acid
peptide-conjugated phosphorodiamidate Morpholino oligomer
phosphatidylserine
RNA dependent RNA polymerase
retinoic acid-inducible gene I
ribonucleoprotein
respiratory syncytial virus
rabies virus
sedimentation equilibrium analytical ultracentrifugation
Sendai virus
small hydrophobic protein
signalling lymphocyte-activation molecule
trans Golgi network
Toll-like receptor 3
transmembrane domain
tumor necrosis factor alpha
Tupaia rhabdovirus
upstream binding factor F
untranslated region
virus-like particle
viral protein 24
viral protein 40
viral genomic RNA
vesicular stomatitis virus
wild type
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